EDEM2、ARFRP1及ERp29对蓖麻毒素逆向转运的作用
摘要
蓖麻毒素(ricin),又称为蓖麻毒蛋白。由A和B两条多肽链组成,其间通过二硫键相连接。A链(ricin A chain, RTA)是活性链,具有N-糖苷酶活性,可催化真核细胞核糖体28S rRNA第4324位腺嘌呤发生脱嘌呤作用,从而抑制蛋白质的合成。B链(ricin B chain, RTB)具有凝集素活性,能够识别和结合细胞表面末端含有半乳糖结构的受体,并协助A链进入细胞。一个毒素分子进入细胞内,就足以使整个细胞的蛋白质合成完全停止而死亡。
一般认为,蓖麻毒素进入细胞涉及到一系列的步骤:1、通过B链与细胞表面含有β-1,4糖苷残基的糖蛋白和糖脂结合;2、通过内吞进入细胞;3、进入早期内涵体;4、通过囊泡转运,毒素进入高尔基体反式外侧网络(TGN);5、逆向转运进入内质网;6、RTA和RTB间的二硫键断裂;7、部分展开折叠的RTA通过Sec61p易位子穿过内质网膜;7与核糖体相互作用,催化脱嘌呤作用。
近期研究表明,由于蓖麻毒素没有专一性的受体,故毒素可能通过多种途径进入细胞内,而且在细胞中的逆向转运的各个过程中,可能也存在不止一种机制起作用。
本研究利用经典的MTS检测、免疫共沉淀和RNAi等技术研究了α甘露糖苷酶样内质网降解增强蛋白2(ER degradation enhancingα–mannosidase-like protein,EDEM2)、ADP-糖基化因子相关蛋白1(ADP-ribosylation factor-related protein 1,ARFRP1)和ERp29对于蓖麻毒素在细胞内逆向转运过程中的作用。
通过研究我们发现:
过量表达EDEM2后提高了细胞对蓖麻毒素的抵抗能力,检测发现细胞的蓖麻毒素的总量并没有改变。细胞转染EDEM2后,用嘌呤霉素处理的细胞对蓖麻毒素的敏感性明显提高。免疫共沉淀结果显示,嘌呤霉素处理后,更多的蓖麻毒素与EDEM2发生作用,也有更多的蓖麻毒素通过Sec61p蛋白通道进入胞浆。Kifunensine抑制EDEM2与错误折叠蛋白的作用后,显著地提高了蓖麻毒素A链的逆向转运。免疫共沉淀证明,kifunensine能够显著提高蓖麻毒素与EDEM2以及蓖麻毒素与Sec61α的相互作用。
转染ARFRP1(wt)和ARFRP1(Q97/L)后,细胞对毒素的敏感性明显增强,转染ARFRP1(T31/N)后,细胞抵抗毒素的能力有一定的提高。同时,转染后的细胞中蓖麻毒素的总量没有明显变化。用BFA处理细胞后,蓖麻毒素对细胞的毒性显著降低,但转染ARFRP1和ARFRP1(Q97/L)的细胞对毒素的敏感性依然较高。转染后的细胞加入蓖麻毒素后低温诱导培养24h后,细胞毒性检测结果表明。低温诱导对表达ARFRP1和ARFRP1(T31/N)的细胞影响更大。
过量表达ERp29蛋白后,CHO-K1细胞对蓖麻毒素的敏感性明显提高,内质网中糖基化的蓖麻毒素A链明显增加。而抑制细胞内ERp29蛋白的表达后,细胞抵抗蓖麻毒素的能力升高,与对照细胞相比,进入内质网的糖基化的蓖麻毒素的量相对减少。免疫共沉淀结果显示,过量表达ERp29蛋白后,有更多的蓖麻毒素与Sec61α相互作用,而干扰ERp29蛋白表达后,与Sec61α作用的蓖麻毒素相应减少。
本研究首次证实EDEM2、ARFRP1及ERp29影响蓖麻毒素细胞内转运过程,尤其是国内外迄今仍未见有过ERp29参与蛋白质毒素逆向转运的相关报道。
Ricinus communis is belong to the Euphorbiaceae Ricinus, which is the one of top ten oil crops. Our contry is one of major cultivated region. The area which cultiveated caster bean plant is seven million Mu, and harvests 300 thousand ton castor bean every year, which is second place in the world. According to statistics, the quantity which castor bean been usea to product castor oil is one million ton. There have 5% ricin in the waste left over from processing castor beans. Ricin is one of glycoprotein, and a prototype ribosome-inactivating protein. The tertiary structure of ricin was shown to be a globular, glycosylated heterodimer in which ricin A chain and ricin B chain are joined by a single disulphide bond. Ricin A chain is an RNA-specific N-glycosidase that hydrolytically cleaved the N-glycosidic bond of the adenine residue at position 4324 (A4324) within the 28S rRNA of eukaryotic cell and fatally disrupted protein synthesis in the end. Ricin B chain is an agglutinant, which can identify and bind terminal galactose residues on cell surface components. Ricin is one most toxin in the native poison up to now. It has been reported that a single molecule of ricin reaching the cytosol can kill that cell as a consequence of protein synthesis inhibition.
Ricin can use many molecules, channels and mechanisms of target cells. The ready availability of ricin, coupled to its extreme potency when administered intravenously or if inhaled, has identified this protein toxin as a potential biological warfare agent. Therapeutically, its cytotoxicity has encouraged the use of ricin in‘magic bullets’to specifically target and destroy cancer cells, and the unusual intracellular trafficking properties of ricin potentially permit its development as a vaccine vector.
Cell entry by ricin involves a series of steps: (i) binding, via the ricin B chain (RTB), to a range of cell surface glycolipids or glycoproteins havingβ-1,4-linked galactose residues; (ii) uptake into the cell by endocytosis; (iii) entry of the toxin into early endosomes; (iv) transfer, by vesicular transport, of ricin from early endosomes to the trans-Golgi network; (v) retrograde vesicular transport through the Golgi complex to reach the endoplasmic reticulum; (vi) reduction of the disulphide bond connecting the ricin A chain (RTA) and the RTB; (vii) partial unfolding of the RTA to render it translocationally-competent to cross the endoplasmic reticulum (ER) membrane via the Sec61p translocon in a manner similar to that followed by misfolded ER proteins that, once recognised, are targeted to the ER-associated protein degradation (ERAD) machinery; (viii) avoiding, at least in part, ubiquitination that would lead to rapid degradation by cytosolic proteasomes immediately after membrane translocation when it is still partially unfolded; (ix) refolding into its protease-resistant, biologically active conformation; and (x) interaction with the ribosome to catalyse the depurination interaction .
For no special receptor on the cell surface, ricin can exploit several mechanisms of internalization. As endocytosis, more than one mechanisms are involved in the transport of ricin.
In the studys, we investigated the role of EDEM2,ARFRP1 and ERp29 in the retrotranslocation of ricin in the cell by the classic MTS method, co-immunoprecipitation and RNAi.
In research to the influence of EDEM2 in retrotranslocation of ricin, HEK293T cells was transiently transfected with pRK7-EDEM2-HA by Lipofectamine 2000 according to manufacturer`s procedure. Three days posttransfection, cells were grown in complete medium DMEM supplemented with 30μg/mL ricin under 5% CO2 in a 37℃incubator for 24h. Optionally, the cells were preincubated with inhibitors(lactose(0.1mol/L),Kifunensine(0.2mmol/L)or puromycin(0.5mg/L)respectively) for 30 min before ricin was added. After extracted total protein in the cells, the sample were detected by western Blot, and a part of sample were immunoprecipitated using mouse anti-HA, mouse anti-RTA or rabbit anti-Sec61αantibody. Moreover, we got RTA in the cytosol by cells` permeabilization using KOAc containing 3μg/mL digitonin, and detected the change of RTA quantity in the cytosol. For investigation the cytotoxicity change influenced by EDEM2, HEK293T cells(1×104 cells in each well) were seeded in 96-well plates and transfected with pRK7-EDEM2-HA vector, then added ricin(concetrations of ricin were 100,10,1,0.1 or 0.01μg/mL, respectively) as before. After the incubation period, added 10μL of the MTS to each well and incubated the microtiter plater for 4h in a humidified atmoshpere. Then measure the spectrophotometrical absorbance of the asmples using a microtiter plate (ELISA) reader. The wavelength to measure absorbance of the product is 490 nm.
In research to the effect of ARFRP1 in the retrotranslocation of ricin, CHO-K1 cells was transiently transfected with pcDNA3-ARFRP1(wt)-HA, pcDNA3-ARFRP1(Q97/L)-HA or pcDNA3-ARFRP1(T31/N)-HA by Lipofectamine 2000 according to manufacturer`s procedure. Three days posttransfection, cells were grown in complete medium F12-K supplemented with 10μg/mL ricin under 5% CO2 in a 37℃incubator for 24h. there was one group was preincubated with 2μg/L brefeldin A for 30 min before ricin was added. Other group was incubated in a 4℃incubator for 24h after ricin was added. The detected of cytotoxicity was operated as before.
In research to the interaction between the ERp29 and ricin in the retrotranslocation of ricin, we amplified ERp29 gene from the liver of Harlan Sprague-Dawley rat by RT-PCR, the primers using in the RT-PCR were : ERp29-1:5`-AAgCTTATggCCgCCgCCgCCggggTg-3`, ERp29-2:5`-CTCgAgCAgCTCCTC CTTCTCAgCCTC-3`. Then we cloned the gene into the pMD18-T vector, and got the pMD18-T-ERp29 vector. The vector was identified by PCR, double enzyme digestio with HindⅢand Xho I and sequencing. The final we further got pcDNA3-ERp29-HA expression vector using the pcDNA3-HA vector. The result of identification of vector was positive.
CHO-K1 cells was transiently transfected with pcDNA3-ERp29-HA. The ricin was recombinant ricin which ricin A chain with C terminal glycosylation sites. Then we detected the cytotoxicity by MTS and the change of quantity of ricin in the ER or cytosol. For further affirmation the role of ERp29 in the retrotranslocation of ricin. We used RNAi in study. At first, transfected-cells were selected with 400μg/mL G418. we got the stably transfected ERp29 cells and used them as control in later study. Two siRNA duplexes(siRNA1: 5`-AGUUCGUCUUGGUGAAGUU-3`, siRNA2:5`- AGCUGAACAUGGAGCUGAG-3`) with symmetric dTdT overhand were chemically synthesized by GenePharma. Transfections were performed using Lipofectamine 2000 transfection reagent according to the manufacturer`s preotocol. ERp29 silencing achieved its maximum after 6 days by RT-PCR and Western Blot identity. Then we done the cytotoxicity assay and studied the quantity of ricin in the ER or cytosol.
By the experiment, we found that:
There was a protection against ricin in EDEM-transfected cells, the interaction did not influced by lactose, meanwhile the total quantity of ricin in the cell did not changed. Ppuromycin was found to sensitize both control and EDEM-transfected cells to ricin. Importantly, in EDEM-transfected cells the observed sensitization was higher than the sensitization seen in mock-transfected cells which could be observed by the rncreased retratranslocation of ricin to the cytosol. Treatment of HA-EDEM2 transfected cells with puromycin resulted in a increase in the amount of ricin co-immunoprecipitated with anti-HA antibody whereas puromycin had an even larger effect on the amount of ricin co-immunoprecipitated with the Sec61αantibody (compared with the amount of ricin found in untreated EDEM-transfected cells). When inhibited the interaction between the EDEM2 and misfolded proteins by kifunensine, more ricin translocated in cytosol. So EDEM2 could promote the retranslocation of ricin under the kifunesine. After kifunensine treatment, not only was there an increased interaction of ricin with EDEM, but more ricin was coimmunoprecipitated with the Sec61 translocon. The results of our data suggested that EDEM2 was also important for ricin retrotranslocation from ER to the cytosol in a different way than the interaction between the EDEM2 and misfolded proteins.
The sensibility of ARFRP1(wt)-/ARFRP1(Q97/L)-transfected cells was higher than the control cells, but cells could against ricin which were overexpressed the ARFRP1(T31/N). In all experiment, the amont of ricin did not changed. The cytotoxicity of ricin decreased by BFA treatment. Otherwise the cells transfected ARFRP1(wt) or ARFRP1(Q97/L) were more sensitive to ricin than control. The sensibilit of ARFRP1(wt)-/ARFRP1(T31/L)-transfected cells were greater influenced by the subzero induction. The result of our date suggested that ARFRP1 could promote the retrotranslocation of ricin in the cell.
CHO-K1 cells which overexpressed ERp29 were more sensitive with ricin, more glycosylated-RTA was observed in the ER and cotosol. Cells could against ricin after interfered the expresion of ERp29, and the amont of ricin in the ER and cotosol notably degraded. More ricin co-immunoprecipitated with Sec61αin the ERp29-transfected cells, but less ricin interaction with Sec61αif interfered the expresion of ERp29. With our date, we presumed that ERp29 could promote ricin into ER and assist the processing and transport of ricin in the ER. Because we did not detected the intereaction between the ricin and ERp29, the mechanism of ERp29 accelerated retrotranslocation of ricin need deeply research.
In this study, we investigated the role of EDEM1, ARFRP1 and ERp29 in the retrotranslocation of ricin in the cell. The results suggested that EDEM2 could promot ricin translocated from ER to cotosol when the intereaction between the EDEM2 and misfolded proteins. ARFRP1 accelerated the ricin transport between the endosome and TGN, the intereaction was more influenced by low temperature than inhibitor. ERp29 could facilitate ricin into ER, and assist the processing and translocation of ricin in the ER.
This study confirmed the intereaction between the EDEM2, ARFRP1 or ERp29 with ricin respectively, especially we have seen any report about the role of ERp29 in the retrotranslocation of protein toxin.
一般认为,蓖麻毒素进入细胞涉及到一系列的步骤:1、通过B链与细胞表面含有β-1,4糖苷残基的糖蛋白和糖脂结合;2、通过内吞进入细胞;3、进入早期内涵体;4、通过囊泡转运,毒素进入高尔基体反式外侧网络(TGN);5、逆向转运进入内质网;6、RTA和RTB间的二硫键断裂;7、部分展开折叠的RTA通过Sec61p易位子穿过内质网膜;7与核糖体相互作用,催化脱嘌呤作用。
近期研究表明,由于蓖麻毒素没有专一性的受体,故毒素可能通过多种途径进入细胞内,而且在细胞中的逆向转运的各个过程中,可能也存在不止一种机制起作用。
本研究利用经典的MTS检测、免疫共沉淀和RNAi等技术研究了α甘露糖苷酶样内质网降解增强蛋白2(ER degradation enhancingα–mannosidase-like protein,EDEM2)、ADP-糖基化因子相关蛋白1(ADP-ribosylation factor-related protein 1,ARFRP1)和ERp29对于蓖麻毒素在细胞内逆向转运过程中的作用。
通过研究我们发现:
过量表达EDEM2后提高了细胞对蓖麻毒素的抵抗能力,检测发现细胞的蓖麻毒素的总量并没有改变。细胞转染EDEM2后,用嘌呤霉素处理的细胞对蓖麻毒素的敏感性明显提高。免疫共沉淀结果显示,嘌呤霉素处理后,更多的蓖麻毒素与EDEM2发生作用,也有更多的蓖麻毒素通过Sec61p蛋白通道进入胞浆。Kifunensine抑制EDEM2与错误折叠蛋白的作用后,显著地提高了蓖麻毒素A链的逆向转运。免疫共沉淀证明,kifunensine能够显著提高蓖麻毒素与EDEM2以及蓖麻毒素与Sec61α的相互作用。
转染ARFRP1(wt)和ARFRP1(Q97/L)后,细胞对毒素的敏感性明显增强,转染ARFRP1(T31/N)后,细胞抵抗毒素的能力有一定的提高。同时,转染后的细胞中蓖麻毒素的总量没有明显变化。用BFA处理细胞后,蓖麻毒素对细胞的毒性显著降低,但转染ARFRP1和ARFRP1(Q97/L)的细胞对毒素的敏感性依然较高。转染后的细胞加入蓖麻毒素后低温诱导培养24h后,细胞毒性检测结果表明。低温诱导对表达ARFRP1和ARFRP1(T31/N)的细胞影响更大。
过量表达ERp29蛋白后,CHO-K1细胞对蓖麻毒素的敏感性明显提高,内质网中糖基化的蓖麻毒素A链明显增加。而抑制细胞内ERp29蛋白的表达后,细胞抵抗蓖麻毒素的能力升高,与对照细胞相比,进入内质网的糖基化的蓖麻毒素的量相对减少。免疫共沉淀结果显示,过量表达ERp29蛋白后,有更多的蓖麻毒素与Sec61α相互作用,而干扰ERp29蛋白表达后,与Sec61α作用的蓖麻毒素相应减少。
本研究首次证实EDEM2、ARFRP1及ERp29影响蓖麻毒素细胞内转运过程,尤其是国内外迄今仍未见有过ERp29参与蛋白质毒素逆向转运的相关报道。
Ricinus communis is belong to the Euphorbiaceae Ricinus, which is the one of top ten oil crops. Our contry is one of major cultivated region. The area which cultiveated caster bean plant is seven million Mu, and harvests 300 thousand ton castor bean every year, which is second place in the world. According to statistics, the quantity which castor bean been usea to product castor oil is one million ton. There have 5% ricin in the waste left over from processing castor beans. Ricin is one of glycoprotein, and a prototype ribosome-inactivating protein. The tertiary structure of ricin was shown to be a globular, glycosylated heterodimer in which ricin A chain and ricin B chain are joined by a single disulphide bond. Ricin A chain is an RNA-specific N-glycosidase that hydrolytically cleaved the N-glycosidic bond of the adenine residue at position 4324 (A4324) within the 28S rRNA of eukaryotic cell and fatally disrupted protein synthesis in the end. Ricin B chain is an agglutinant, which can identify and bind terminal galactose residues on cell surface components. Ricin is one most toxin in the native poison up to now. It has been reported that a single molecule of ricin reaching the cytosol can kill that cell as a consequence of protein synthesis inhibition.
Ricin can use many molecules, channels and mechanisms of target cells. The ready availability of ricin, coupled to its extreme potency when administered intravenously or if inhaled, has identified this protein toxin as a potential biological warfare agent. Therapeutically, its cytotoxicity has encouraged the use of ricin in‘magic bullets’to specifically target and destroy cancer cells, and the unusual intracellular trafficking properties of ricin potentially permit its development as a vaccine vector.
Cell entry by ricin involves a series of steps: (i) binding, via the ricin B chain (RTB), to a range of cell surface glycolipids or glycoproteins havingβ-1,4-linked galactose residues; (ii) uptake into the cell by endocytosis; (iii) entry of the toxin into early endosomes; (iv) transfer, by vesicular transport, of ricin from early endosomes to the trans-Golgi network; (v) retrograde vesicular transport through the Golgi complex to reach the endoplasmic reticulum; (vi) reduction of the disulphide bond connecting the ricin A chain (RTA) and the RTB; (vii) partial unfolding of the RTA to render it translocationally-competent to cross the endoplasmic reticulum (ER) membrane via the Sec61p translocon in a manner similar to that followed by misfolded ER proteins that, once recognised, are targeted to the ER-associated protein degradation (ERAD) machinery; (viii) avoiding, at least in part, ubiquitination that would lead to rapid degradation by cytosolic proteasomes immediately after membrane translocation when it is still partially unfolded; (ix) refolding into its protease-resistant, biologically active conformation; and (x) interaction with the ribosome to catalyse the depurination interaction .
For no special receptor on the cell surface, ricin can exploit several mechanisms of internalization. As endocytosis, more than one mechanisms are involved in the transport of ricin.
In the studys, we investigated the role of EDEM2,ARFRP1 and ERp29 in the retrotranslocation of ricin in the cell by the classic MTS method, co-immunoprecipitation and RNAi.
In research to the influence of EDEM2 in retrotranslocation of ricin, HEK293T cells was transiently transfected with pRK7-EDEM2-HA by Lipofectamine 2000 according to manufacturer`s procedure. Three days posttransfection, cells were grown in complete medium DMEM supplemented with 30μg/mL ricin under 5% CO2 in a 37℃incubator for 24h. Optionally, the cells were preincubated with inhibitors(lactose(0.1mol/L),Kifunensine(0.2mmol/L)or puromycin(0.5mg/L)respectively) for 30 min before ricin was added. After extracted total protein in the cells, the sample were detected by western Blot, and a part of sample were immunoprecipitated using mouse anti-HA, mouse anti-RTA or rabbit anti-Sec61αantibody. Moreover, we got RTA in the cytosol by cells` permeabilization using KOAc containing 3μg/mL digitonin, and detected the change of RTA quantity in the cytosol. For investigation the cytotoxicity change influenced by EDEM2, HEK293T cells(1×104 cells in each well) were seeded in 96-well plates and transfected with pRK7-EDEM2-HA vector, then added ricin(concetrations of ricin were 100,10,1,0.1 or 0.01μg/mL, respectively) as before. After the incubation period, added 10μL of the MTS to each well and incubated the microtiter plater for 4h in a humidified atmoshpere. Then measure the spectrophotometrical absorbance of the asmples using a microtiter plate (ELISA) reader. The wavelength to measure absorbance of the product is 490 nm.
In research to the effect of ARFRP1 in the retrotranslocation of ricin, CHO-K1 cells was transiently transfected with pcDNA3-ARFRP1(wt)-HA, pcDNA3-ARFRP1(Q97/L)-HA or pcDNA3-ARFRP1(T31/N)-HA by Lipofectamine 2000 according to manufacturer`s procedure. Three days posttransfection, cells were grown in complete medium F12-K supplemented with 10μg/mL ricin under 5% CO2 in a 37℃incubator for 24h. there was one group was preincubated with 2μg/L brefeldin A for 30 min before ricin was added. Other group was incubated in a 4℃incubator for 24h after ricin was added. The detected of cytotoxicity was operated as before.
In research to the interaction between the ERp29 and ricin in the retrotranslocation of ricin, we amplified ERp29 gene from the liver of Harlan Sprague-Dawley rat by RT-PCR, the primers using in the RT-PCR were : ERp29-1:5`-AAgCTTATggCCgCCgCCgCCggggTg-3`, ERp29-2:5`-CTCgAgCAgCTCCTC CTTCTCAgCCTC-3`. Then we cloned the gene into the pMD18-T vector, and got the pMD18-T-ERp29 vector. The vector was identified by PCR, double enzyme digestio with HindⅢand Xho I and sequencing. The final we further got pcDNA3-ERp29-HA expression vector using the pcDNA3-HA vector. The result of identification of vector was positive.
CHO-K1 cells was transiently transfected with pcDNA3-ERp29-HA. The ricin was recombinant ricin which ricin A chain with C terminal glycosylation sites. Then we detected the cytotoxicity by MTS and the change of quantity of ricin in the ER or cytosol. For further affirmation the role of ERp29 in the retrotranslocation of ricin. We used RNAi in study. At first, transfected-cells were selected with 400μg/mL G418. we got the stably transfected ERp29 cells and used them as control in later study. Two siRNA duplexes(siRNA1: 5`-AGUUCGUCUUGGUGAAGUU-3`, siRNA2:5`- AGCUGAACAUGGAGCUGAG-3`) with symmetric dTdT overhand were chemically synthesized by GenePharma. Transfections were performed using Lipofectamine 2000 transfection reagent according to the manufacturer`s preotocol. ERp29 silencing achieved its maximum after 6 days by RT-PCR and Western Blot identity. Then we done the cytotoxicity assay and studied the quantity of ricin in the ER or cytosol.
By the experiment, we found that:
There was a protection against ricin in EDEM-transfected cells, the interaction did not influced by lactose, meanwhile the total quantity of ricin in the cell did not changed. Ppuromycin was found to sensitize both control and EDEM-transfected cells to ricin. Importantly, in EDEM-transfected cells the observed sensitization was higher than the sensitization seen in mock-transfected cells which could be observed by the rncreased retratranslocation of ricin to the cytosol. Treatment of HA-EDEM2 transfected cells with puromycin resulted in a increase in the amount of ricin co-immunoprecipitated with anti-HA antibody whereas puromycin had an even larger effect on the amount of ricin co-immunoprecipitated with the Sec61αantibody (compared with the amount of ricin found in untreated EDEM-transfected cells). When inhibited the interaction between the EDEM2 and misfolded proteins by kifunensine, more ricin translocated in cytosol. So EDEM2 could promote the retranslocation of ricin under the kifunesine. After kifunensine treatment, not only was there an increased interaction of ricin with EDEM, but more ricin was coimmunoprecipitated with the Sec61 translocon. The results of our data suggested that EDEM2 was also important for ricin retrotranslocation from ER to the cytosol in a different way than the interaction between the EDEM2 and misfolded proteins.
The sensibility of ARFRP1(wt)-/ARFRP1(Q97/L)-transfected cells was higher than the control cells, but cells could against ricin which were overexpressed the ARFRP1(T31/N). In all experiment, the amont of ricin did not changed. The cytotoxicity of ricin decreased by BFA treatment. Otherwise the cells transfected ARFRP1(wt) or ARFRP1(Q97/L) were more sensitive to ricin than control. The sensibilit of ARFRP1(wt)-/ARFRP1(T31/L)-transfected cells were greater influenced by the subzero induction. The result of our date suggested that ARFRP1 could promote the retrotranslocation of ricin in the cell.
CHO-K1 cells which overexpressed ERp29 were more sensitive with ricin, more glycosylated-RTA was observed in the ER and cotosol. Cells could against ricin after interfered the expresion of ERp29, and the amont of ricin in the ER and cotosol notably degraded. More ricin co-immunoprecipitated with Sec61αin the ERp29-transfected cells, but less ricin interaction with Sec61αif interfered the expresion of ERp29. With our date, we presumed that ERp29 could promote ricin into ER and assist the processing and transport of ricin in the ER. Because we did not detected the intereaction between the ricin and ERp29, the mechanism of ERp29 accelerated retrotranslocation of ricin need deeply research.
In this study, we investigated the role of EDEM1, ARFRP1 and ERp29 in the retrotranslocation of ricin in the cell. The results suggested that EDEM2 could promot ricin translocated from ER to cotosol when the intereaction between the EDEM2 and misfolded proteins. ARFRP1 accelerated the ricin transport between the endosome and TGN, the intereaction was more influenced by low temperature than inhibitor. ERp29 could facilitate ricin into ER, and assist the processing and translocation of ricin in the ER.
This study confirmed the intereaction between the EDEM2, ARFRP1 or ERp29 with ricin respectively, especially we have seen any report about the role of ERp29 in the retrotranslocation of protein toxin.
引文
[1] Lord J M, Roberts L M, Robertus J D, et al. Ricin: strcture, mode of actin and some current applications. FASEB J, 1994, 8: 201.
[2] Robert B, John F H, Mark A, et al. Ricin: mechanism of action, detection and intoxication. J Toxiol, 1995, 14: 483.
[3] Franz D R, Aaz N K. Medical aspects of chemical and biologicalwarfare, chapter 32, ricin toxin, fall church . VA: Office of the Surgeon General, 1997: 631
[4] Stillmark. Ueber Ricen. Arbeiten des Pharmacologischen Institutes zu Dorpat, iii, 1889. Cited in: Flexner. The histological changes produced by ricin and abrin intoxications. J Exp Med. 1897;2:197~216.
[5] Bernhijmer A W. Perspectives in toxinology, Abrin and Ricin: two toxic tectins inactivating eukaryotic ribosome. 1977, sju R. Olsnes(eds), Awiley Medical publication.
[6] Ehrlich P. Experimentelle Untersuchungen über Immunit?t, I: Euber Ricin. Deutsch Med Wochenschr. 1891;17:976~979
[7] Olsnes S, Pihl A. Abrin, ricin, and their associated agglutinins. In: Cuatrecasas P, ed. Receptors and Recognition: The Specificity and Action of Animal, Bacterial, and Plant Toxins. London, England: Chapman and Hall; 1976: 129~173.
[8] Olsnes S, Pihl A. Construction and properties of chimeric toxins target specific cytotoxic agents. In: Dorner F, Drews J, eds. Pharmacology of Bacterial Toxins. New York, NY: Pergamon Press; 1986: 709~739.
[9] Magerstadt M. Therapeutic aminoconjugates. In: Antibody Conjugates and Malignant Disease. Boca Raton, Fla: CRC Press; 1991: Chap 3.
[10] Ucken F, Frankel A. The current status of immunotoxins: An overview of experimental and clinical studies as presented at the 3rd International Symposium on Immunotoxins. Leukemia. 1993;7:341~348
[11] Vitetta E, Thorpe P, Uhr J. Immunotoxins: Magic bullets or misguided missiles? Trends Pharmacol Sci. 1993;14(5):148~154.
[12] Vitetta E, Krolick K, Muneo M, Cushley W, Uhr J. Immunotoxins: A new approach to cancer therapy. Science. 1983;219:644~649.
[13] Thorpe PE, Mason DW, Brown AN, et al. Selective killing of malignant cells in leukemic rat bone marrow using an antibody–ricin conjugate. Nature . 1982;297:594~596.
[14] Cookson J, Nottingham J. A Survey of Chemical and Biological Warfare. New York, NY: Monthly Review Press. 1969: 6.
[15] Ramesh Hegde. Studies of the variants of the protein toxins Ricin and Abrin. Eur. J.Biochem.1992, 204, 155~164.
[16] Cawley B D. Homogy between Ricin and Ricinus communis agglutinin: Amino terminal sequence analysis and protein synthesis inhibition studies. Archives of Biochemistry and Biophysics, 1978,190: 744~755.
[17] Lord J M, Roberts L M, Robertus J D, et al. Ricin: strcture, mode of actin and some current applications. FASEB J, 1994, 8: 201~204.
[18] Robertus J. Toxin structure. In: Frankel A, ed. Immunotoxins. Boston, Mass: Kluwer Academic Publishers; 1988: 11~24.
[19] Dietrich J B, Ribereau G G, Jung M L. Identity of the N-terminal sequences of the three A chains of mistletoe lectins: homology with ricin-like plant toxin and single-chain ribosome inhibiting proteins. Anticancer Drugs, 1992, 3: 507~511.
[20] Morris K N. Proc. Natl. Acad. Sci. USA, 1992,89:48~69.
[21] Katzin B J, Collins E J, Robertus J D. Structure of ricin A-chain at 2.5 A° . Proteins, 1991; 10: 251~259.
[22] Mlsna D, Monzingo A F, Katzin B J, et al. Structure of recombinant ricin A-chain at 2.3 A° resolution. Protein Sci 1993; 2: 429~435.
[23] Weston SA, Tucker AD, Thatcher DR, et al. X-ray structure of recombinant ricin A-chain at 1.8 A° resolution. J Mol Biol 1994; 244: 410~22.
[24] Burlet A, Chapleur C M, Haumont P B. Long-term reduction of vasopressin excretion induced by the central injection of an immunoconjugate. Neruoscience, 1992, 50: 965~973.
[25] Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain: mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 1987; 262: 8128~8130.
[26] Lewis M S, Youle R J. Ricin subunit association: thermodynamics and the role ofthe disulfide bond. J Biol Chem, 1986; 261: 11571~11577.
[27] Wright H T, Robertus J D. The intersubunit disulfide bridge of ricin is essential for cytotoxicity. Arch Biochem Biophys,1987; 256: 280~284.
[28] Endo Y, Tsurugi K. The RNA N-glycosidase activity of ricin A-chain. J Biol Chem 1988; 263: 8735~8739.
[29] Wool I G, Correll C C, Yuen-Ling C. Structure and function of the sarcin-ricin domain. In: Garrett J, Douthwaite L, Lilias P J, et al., editors. The ribosome structure, function, antibiotics and cellular interactions. Washington, DC: ASM Biochem, 1981; 119: 31~4 Press, 2000: 461~473.
[30] Ban N, Nissen P, Hansen J, et al. Placement of protein and RNA structures into a 5A° -resolution map of the 50S ribosomal subunit. Nature 1999; 400: 841~847.
[31] Sperti S, Montanaro L, Mattioli A, et al. Inhibition by ricin of protein synthesis in vitro: 60 S ribosomal subunit as the target of the toxin. Biochem J, 1973; 136: 813~815.
[32] Nilsson L, Nygard O. The mechanism of the protein synthesis elongation cycle in eukaryotes: effect of ricin on the ribosome interaction with elongation factors. Eur J Biochem, 1986; 161: 111~117.
[33] Hartley M R, Legname G, Osborn R, et al. Single-chain ribosome-inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett 1991; 290: 65~68.
[34] Cawley D B, Hedbolm M L, Hoffman E J, et al. Differential sensitivity of rat liver and wheat germ ribosomes to inhibition of polyuridylic acid translation by ricin A chain. Arch Biochem Biophys, 1977; 182: 690~695
[35] Monzingo A F, Robertus J D. X-ray analysis of substrate analogs in the ricin A- chain active site. J Mol Biol, 1992; 227: 1136~1145.
[36] Villafranca J E, Robertus J D. Ricin B chain is the product of gene duplication. J Biol Chem, 1981; 256: 554~556.
[37] Ramakrishnan S F, Mohavraj D. Cytotoxic conjugates containing translational inhibitory proteins, Ann Rev Pharmacol Toxicol, 1992, 32: 579.
[38] Magnusson S., Kjeken R., Berg T. Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells. Exp. Cell. Res., 1993, 205:118~125.
[39] Riccobono F., Fiani M. L. Mannose receptor dependent uptake of ricin A1 and A2 chains by macrophage. Carbohydr Res,1996, 282(2): 285~292.
[40] Fu T. ,Burbage C. and Tagge E. ,Double - lectin site ricin B chain mutants espressed in insect cells have residual galactose binding : evidence for more than two lectin site on the ricin toxin B chain.Bioconjug Chem, 1996 ;7 (6) :651~658.
[41] Barbieri L, Valbonesi P, Bonora E, et al. Polynucleotide: adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly A. Nucleic Acids Res, 1997; 25: 518~522.
[42] Brigotti M, Alfies R, Sestili P, et al. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J, 2002; 16: 365~372.
[43] Barbieri L, Valbonesi P, Righi F, et al. Polynucleotide: adenosine glycosidase is the sole activity of ribosome-inactivating proteins on DNA. J Biochem (Tokyo), 2000; 128: 883~889
[44] Day P J, Lord J M, Roberts L M. The deoxyribonuclease activity attributed to ribosome- inactivating proteins is due to contamination. Eur J Biochem, 1999; 258: 540~545.
[45] van Damme E, Hao Q, Chen Y, et al. Ribosome-inactivating proteins: a family of plant proteins that do more than inactivate ribosomes. Crit Rev Plant Sci, 2001; 20: 395~465
[46] Barbieri L, Valbonesi P, Bonora E. Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly A. Nucleic Acids Res, 1997; 25: 519~522
[47] Peumans W J, Hao Q, van Damme E J. Ribosome-inactivating proteins from plants: more that RNA N-glycosidases? FASEB J, 2001; 15: 1493~1506
[48] Balint G A. Ricin: The toxic protein of castor oil seeds. Toxicology, 1974;2(1): 77~102.
[49] Wannemaker R. Assistant Division Chief, Toxinology Division, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Md. Personal communication, September 1994.
[50] Lord J M, Roberts L M, Robertus J D. Ricin: structure, mode of action, and somecurrent applications. FASEB J 1994; 8: 201~208.
[51] Butterworth A G, Lord J M. Ricin and Ricinus communis agglutinin subunits are all derived from a single-size polypeptide precursor. Eur J Biochem 1983; 137: 56~62.
[52] Ferrini J B, Martin M, Taupiac M P, et al. Expression of functional ricin B chain using the baculovirus system. Eur J Biochem, 1995; 233: 772~777.
[53] Lamb F I, Roberts LM, Lord J M. Nucleotide sequence of cloned cDNA coding for preproricin. Eur J Biochem, 1985; 148: 265~270.
[54] Lord J M. Precursors of ricin and Ricinus communis agglutinin: glycosylation and processing during synthesis and intracellular transport. Eur J Biochem 1985; 146: 411~416.
[55] Roberts L M, Lord J M. The synthesis of Ricinus communis agglutinin. Eur J Biochem, 1981; 119: 31~34.
[56] Lord J M. Synthesis and intracellular transport of lectin and storage protein precur sors in endosperm from castor bean. Eur J Biochem 1985; 146: 403~409.
[57] Lord J M, Harley S M. Ricinus communis agglutinin B chain contains a fucosylated oligosaccharide side chain not present on ricin B chain. FEBS Lett, 1985: 189; 72~76
[58] Harley S M, Lord J M. In vitro endoproteolytic cleavage of castor bean lectin precursors. Plant Sci, 1985; 41: 111~116.
[59] Frigerio L, Vitale A, Lord J M, et al. Free ricin A chain, proricin and native toxin have different cellular fates when expressed in tobacco protoplasts. J Biol Chem, 1998; 273: 14194~14199.
[60] Frigerio L, Jolliffe N A, Di Cola A, et al. The internal propeptide of the ricin precursor carries a sequence-specific determinant for vacuolar sorting. Plant Physiol, 2001; 126: 167~175.
[61] Jolliffe N A, Ceriotti A, Frigerio L, et al. The position of the proricin vacuolar targeting signal is functionally important. Plant Mol Biol, 2003; 41: 825~835.
[62] Ramesh Hegde, et al. Studies of the variants of the protein toxins Ricin and Abrin. Eur. J.Biochem.1992, 204, 155~164.
[63] Sjur Olsnes, et al. Different biological properties of the two constituent peptidechains of ricin, a toxic protein inhibiting protein synthesis. Biochemistry, 1973,12: 3121~3126.
[64] Jon D, et al. Crystallization of Ricin A chain obtained from a cloned gene expressed in Escherichia coli. Biol Chem.,1987,262: 19~20.
[65] Hare O M, et al. Expression of Ricin A chain in Escherichia coli. FEBS Lett., 1987,216: 73~78.
[66] Hailling K, et al. Genomic cloning and characterization of a ricin gene from Ricinus communis Nucl.. Acids Res., 1985,13: 8019~8033.
[67] Tagge E P, et al. Preproricin expressed in Nicotiana tobacum cells in vitro is fully processed and biologically active. Protein Exprpurif, 1996,8: 109~118.
[68] Richardson P T, Westby M, Roberts L M, et al. Recombinant proricin binds galactose but does not depurinate 28S ribosomal RNA. FEBS Lett 1989; 255: 15~20.
[69] Lewis M S, Youle R J. Ricin subunit association: thermodynamics and the role of the disulfide bond. J Biol Chem, 1986; 261: 11571~11577.
[70] Wright H T, Robertus J D. The intersubunit disulfide bridge of ricin is essential for cytotoxicity. Arch Biochem Biophys, 1987; 256: 280~284.
[71] Harley S M, Beevers H. Ricin inhibition of in vivo protein synthesis by plant ribosomes. Proc Natl Acad Sci, 1982; 79: 5935~5938.
[72] Taylor S, Massiah A, Lomonossoff G, et al. Correlation between the activities of five ribosome-inactivating proteins in depurination of tobacco ribosomes and inhibition of tobacco mosaic virus infection. Plant J, 1994; 5: 827~835.
[73] Ghosh P, Wellner R, Cragoe E, Wu H. Enhacement of ricin cytotoxicity in Chinese hamster ovary cells by depletion of intracellular K+: Evidence for Na+/H+ exchange system in Chinese hamster ovary cells. J Cell Biol, 1985,101: 350~357.
[74] Moya M, Dautry-Varsat A, Goud B, Louvard D, Boquet P. Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diptheria toxin but not that of ricin toxin. J Cell Biol, 1985, 101(2): 548~559.
[75] Sandvig K, Olsnes S, Pihl A. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells. J Biol Chem, 1976, 251(13):3977~3984.
[76] Lord J M, Roberts L M, Robertus J D. Ricin: Structure, mode of action, and some current applications. FASEB J. 1994, 8:201~208.
[77] Hudson T, Neville D. Temporal separation of protein toxin translocation from processing events. J Biol Chem, 1987, 262:16484~16494.
[78] Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes: The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J Biol Chem. 1987;262(12):5908~5912.
[79] Olsnes S, Pihl A. Toxic lectins and related proteins. In: Cohen P, van Heyningen S, eds. Molecular Action of Toxins and Viruses. Amsterdam, Netherlands: Elsevier Biomedical Press; 1982: 51~105.
[80] Wilhelmsen C, Pitt L. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet Pathol, 1993, 30: 482
[81] Crompton R, Gall D. Georgi Markov: Death in a pellet. Med Leg J, 1980, 48: 51~62.
[82] Patocka J . Abrin and Ricin: two dangerous poisonous proteins. http://www.asabktr.cin/newsletter/01- 4/articles/Abrin &RicinRev.Pdf
[83] Kortepeter M, Christopher G, Cieslak J . et al . USAMR II D’ s Medical Management of Biological casualitites Handbook: Biological toixns. Fourth Edition. http://www.vnh.org/BIOCASU/toc.html
[84] Sjur O S, Refsnes K, Pihl A , et al. M echanism of action of the toxic lectins abrin and ricin. N ature, 1974, 249: 627~631.
[85] Olsnes S. Closing in on ricin action. Nature, 1987,328: 474~475.
[86] Fu T, Burbage C, Tagge E, et al. R icin toxin contains th ree lectin sites wh ich contribute to its in vivo toxicity. Int J Immunopharmaco l, 1996, 18: 685~692.
[87] Tracey K J , Beutler B, Lowry S F, et al. Shock and tissue injury induced by recombinant human cachetin. Science, 234: 470~474
[88] Licastro F, Morini M C, Bolognesi A , et al. Ricin induced the production of tumor necrosis facto ralpha and interleuk in 21 beta by human peripheral2blood mononuclear cells. Biochem J , 1993, 294: 517~520.
[89] Muldoon D F, Bagchi D, Hassoun E A , et al. Themodulating effects of tumo r necro sis factor alpha antibody on ricin-induced oxidative stress in mice. J Biochem Toxico, 1994, 9: 311~318.
[90] 董巨莹, 王剑波, 王文学. 蓖麻毒素诱导小鼠肝脏产生肿瘤坏死因子. 第四军医大学学报, 1997, 18: 78.
[91] Muldoon D F, Stohes S J. Ricin-induced oxidative stress in mice. Toxico logist, 1991, 11: 214.
[92] Muldoon D F, Hassoun E A , Stohs S J. Ricin-induced hepatic lipid peroxidation, glutathione depletion and DNA single-strand break s in mice. Toxicon, 1992, 30: 977~984.
[93] Corwin A H. Toxic constituents of the castor bean. J M ed Pharm Chem, 1961, 4: 483~496.
[94] Muldoon D F, Hassoun E A , Stohes S J. Ro le of iron in ricin-induced lipid peroxidation and superoxide production. Res Commun Mo Patho Pharmaco, 1996, 92: 107~118
[95] Leek M D, Griffiths G D, Green M A. Intestinal patho logy follow ing intramuscular ricin poisoning. J Patho l, 1989, 159: 329~334.
[96] Waring P. DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded raised ino sitotripho sphate levels. J Bio l Chem, 1990, 265: 14476~14480
[97] Khan T, Waring P. Macrophage adherence prevents apoptosis induced by ricin. Eur J Cell Bio l, 1993, 62: 406~414.
[98] 江渝. 程序型细胞死亡的生物化学基础. 国外医学临床生物化学与检验学分册, 1996, 17: 178~182.
[99] Benis J. Signal transduction via the MAP kinase: proceed at your own RSK. Proc Natl Acad Sci USA, 1993, 91: 5889~5992.
[100] Lin JY. A brin and ricin: New anti-tumour substances. Nature,1970;227(1):292.
[101] Sandra W Key, et al. Researchers know beans about cancer research. Cancer Weekly Plus, 1998,11: 20.
[102] Fred Wilson. Immunotoxin safely eliminates local inflammation in two days. Dermatology Times, 2000,21: 18~19.
[103] Weiner L M. Phase I evaluation of an antibreast carcinoma monoclonal antibody 260F9 ricin A chain. Cancer Res., 1989,49: 4062~4067.
[104] 董巨莹,等. 蓖麻毒素及其修饰物对 U937 细胞 IL21B 和 TNF2A 的诱导作用. 细胞与分子免疫学杂志, 1999,15:123~125.
[105] 张会. 包有蓖麻毒素脂质体的制备、性质及毒性研究. 生物化学与生物物理学报, 1999,31: 472~474.
[106] Chignola R. Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with vira l structures. J Bio Chem, 1995,207: 23345~23351.
[107] Lord J. Ricin: structure, mode of action, and some current applications. FASEB J., 1994,8: 201~208.
[108] Lambert J M. , Goldmacher V S. ,and Collinson A R. ,et al. An Immuntoxin prepared with blocked ricin :a natural plant toxin adaped for therapeutic use. Cancer Res. 1991 ;51 (23) :6236~6242
[109] Lambert J M. , Goldmacher V S. ,and Collinson A R. ,et al. An Immuntoxin prepared with blocked ricin :a natural plant toxin adaped for therapeutic use. Cancer Res. 1991 ;51 (23) :6236~6242
[110] 沈演初. 生物农药. 北京: 化学工业出版社, 2000. 72~98.
[111] 赵善欢. 植物化学保护. 北京: 中国农业出版社, 2002. 301~303.
[112] 杜小凤. 植物源农药研究进展. 农药, 2000, 11: 8~10
[113] 蔡东宏. 用淘米水和蓖麻籽的熬出物防治椰子害虫. 世界农业信息, 1995. 9, 69.
[114] 赵建兴. 蓖麻毒素粗提物杀虫作用的研究. 内蒙古农业大学学报, 2001,12: 78~80.
[115] Maruniak J E. Susceptibility of insect cells and ribosomes to ricin. Comparative Biochemistry and Physiology, 1990,96: 543~548.
[116] Frigerio L. The enemy within: Ricin and plant cells. J Exp Botany, 1998,326: 1473~1480.
[117] 吴文君, 胡兆农. 我国植物源害虫控制剂的研究与开发. 农药, 1999, 34(2) : 628.
[118] Sandvig, K. and van Deurs, B. Physiol. Rev, 1996, 76, 949~966.
[119] Llorente, A., Rapak, A., Schmid, S.L., et al. J. Cell Biol, 1998, 140, 1~11.
[120] Rodal, S.K., Skretting, G., Garred, ò., et al. Mol. Biol. Cell , 1999, 9, 472~474.
[121] Sandvig K, van Deurs B. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J, 2000, 19(22): 5943~5950.
[122] Sandvig K, Olsnes S, Pihl A. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells. J Biol Chem, 1976, 251: 3977~3984.
[123] Riccobono F., Fiani M. L. Mannose receptor dependent uptake of ricin A1 and A2 chains by macrophage Carbohydr Res,1996, 282(2): 285~292.
[124] Sandvig, K., Olsnes, S., Petersen, O.W. et al. J. Cell Biol,1987, 105, 679~689.
[125] Sandvig, K. van Deurs, B. Physiol. Rev. 1996, 76, 949~966.
[126] Larkin, J.M., Brown, M.S., Goldstein, J.L. et al. Cell, 1983,33, 273~285.
[127] Moya, M., Datry-Varsat, A., Goud, B., et al. J. Cell Biol, 1985,101, 548~559.
[128] Llorente, A., Rapak, A., Schmid, S.L., et al. J. Cell Biol, 1998, 140, 1~11.
[129] Damke, H., Baba, T., Warnock, D.E. et al. J. Cell Biol, 1994, 127, 915~934.
[130] Liu, S.H., Marks, M.S. Brodsky, F.M. J. Cell Biol, 1998, 140, 1023~1037.
[131] Parton, R.G., Joggerst, B. Simons, K. J. Cell Biol,1994, 127, 1199~1215.
[132] Oh, P., McIntosh, D.P. Schnitzer, J.E. J. Cell Biol, 1998, 141, 101~104.
[133] Henley, J.R., Krueger, E.W.A., Oswald, B.J. et al. J. Cell Biol, 1998, 141, 85~99.
[134] Stang, E., Kartenbeck, J. Parton, R.G. Mol. Biol. Cell,1997, 8, 47~57.
[135] Anderson, H.A., Chen, Y. Norkin, L.C. J. Gen. Virol, 1998, 79, 1469~1477.
[136] Subtil, A., He¨mar, A. Dautry-Varsat, A. J. Cell Sci, 1994, 107, 3461~3468.
[137] Fra A M., Williamson E., Simons K, et al. J. Biol. Chem, 1994, 269, 30745~30748.
[138] Eker P., Holm P K., van Deurs, B, et al. J. Biol. Chem, 1994,269, 18607~18615.
[139] Holm P K, Eker P, Sandvig K et al. Exp.Cell Res, 1995,217, 157~168.
[140] Llorente A., Garred ò., Holm P K., et al. Exp. Cell Res, 1996, 227, 298~308.
[141] Vogel U, Sandvig K, van Deurs B. J. Cell Sci, 1998,111: 825~832.
[142] Scheiele P, Verkade P, Fra A.M et al. J. Cell Biol, 1998, 140: 795~806.
[143] Rothberg K G, Ying Y S, Kamen B A et al. J. Cell Biol, 1990, 111: 2931~2938.
[144] Schnitzer J E. Oh P, Pinney E, et al. J. Cell Biol, 1994,127: 1217~1232.
[145] Pitha J, Irie T, Sklar P B et al. Life Sci, 1988, 43: 493~502.
[146] Hailstones D, Sleer L S, Parton R G et al. J. Lipid Res, 1998,39: 369~379.
[147] Araki N, Johnson M T, Swanson J A. J. Cell Biol, 1996, 135: 1249~1260.
[148] Artalejo C R, Henley J.R, McNiven M A, et al. Proc. Natl Acad Sci, 1995, 92: 8328~8332.
[149] Garred ?., Rodal S. K., van Deurs B., et al. Reconstitution of clathrin- indepe- ndent endocytosis at the apical domain of permeabilized MDCK Ⅱ cells: requirement for a Rho-family GTPase. Traffic 2001, 2: 26~36.
[150] van der Bliek A M, Redelmeier T E, Damke H, et al. J. Cell Biol, 1993, 122: 553~565.
[151] Kirchhausen T. Curr Opin Struct Biol, 1993, 3: 182~188.
[152] Zhang J, Ferguson S S G, Barak L S, et al. J. Biol. Chem, 1996,271: 18302~18305.
[153] Pals-Rylaarsdam R, Gurevich V V, Lee K B, et al. J. Biol. Chem,1997, 272: 23682~23689.
[154] Vickery R G, Zastrow M. J. Cell Biol, 1999, 144: 31~43.
[155] Cao T T, Mays R W, von Zastrov M. J. Biol Chem, 1998, 273: 24592~24602.
[156] Mihail M, Alex T, Natalia M, et al. Endosomal ricin transport:involvement of Rab4- and Rab5-positive compartments. Histochem Cell Biol, 2004, 121: 429~439.
[157] Rodal S.K., Skretting G., Garred, ?., et al. Extraction of cholesterol with methyl-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell, 1999, 10: 961~974.
[158] Rothberg K. G., Ying Y. S., Kamen B. A., et al. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5- methyltetrahydrofolate. J Cell Biol. 1990, 111: 2931~2938.
[159] Lamaze C., Dujeancourt A., Baba T., et al. Interleukin receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell., 2001, 7: 661~671.
[160] Anderson H A, Chen Y, Norkin L C: Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 1996, 7(11):1825~1834.
[161] Pelkmans L, Puntener D, Helenius A: Local actin polymerization and dynaminrecruitment in SV40-induced internalization of caveolae. Science 2002, 296(5567):535~539.
[162] Gilbert J M,artenbeck J, Parton R G: Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 1997, 8(1):47~57.
[163] Gilbert J M, Goldberg I G, Benjamin T L: Cell penetration and trafficking of polyomavirus. J Virol 2003, 77(4):2615~2622.
[164] Gilbert J M, Benjamin T L: Early steps of polyomavirus entry into cells. J Virol 2000, 74(18):8582~8588.
[165] Richterova Z, Liebl D, Horak M,et al: Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol 2001, 75(22):10880~10891.
[166] Damm E M, Pelkmans L, Kartenbeck J,et al: Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol, 2005, 168(3):477~488.
[167] van Deurs B, Tonnessen T. I., Petersen O.W., et al. Routing of internalized ricin and ricin conjugates to the Golgi complex. J Cell Biol., 1986,102: 37~47.
[168] J ? rgen Wesche. Retrograde transport of ricin. IJMM, 2002,291: 517~521.
[169] Ghosh R. An endocytosed TGN38 chimeric protein is delivered to the TGN after trafficking through the endocytic recycling compartment in CHO cells. J Cell Biol 1998, 142:923~936.
[170] Mallard F, Antony C, Tenza D, et al: Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol 1998, 143(4):973~990.
[171] Mallard F, Tang BL, Galli T, et al: Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J Cell Biol 2002, 156(4):653~664.
[172] Mallet W G, Maxfield F R: Chimeric forms of furin and TGN38 are transported with the plasma membrane in the trans-Golgi network via distinct endosomal pathways. J Cell Biol 1999, 146:345~359.
[173] Lombardi D, Soldati T, Riederer M A, et al: Rab9 functions in transport between late endosomes and the trans Golgi network. Embo J 1993, 12(2):677~682.
[174] Sandvig K, Grimmer S, Lauvrak S U, et al: Pathways followed by ricin and Shiga toxin into cells. Histochem Cell Biol, 2002, 117(2):131~141.
[175] Sandvig K, Deurs B. van. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev.,1996, 76: 949~966.
[176] Clague M. J, Urbe S., Aniento F., et al. Vacuolar ATPase activity required for endosomal carrier vesicle formation. J. Biol. Chem.,1994,269:21~24.
[177] Holm P. K, Eker P., Sandvig K., et al. Phorbol myristate acetate selectively stimulates apical endocytosis via protein kinase C in polarized MDCK cells. Exp. Cell Res. 1995., 217: 157~168.
[178] Smith D. C., Gallimore A., Jones E., et al. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processingindependent MHC class I-restricted presentation. J. Immunol., 2002,169, 99~107.
[179] Sandvig K. Bo van Deurs. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS, 2002(529): 49~53.
[180] Sandvig, K., Grimmer, S., Lauvrak, S. U., et al. Pathways followed by ricin and Shiga toxin into cells. Histochem. Cell. Biol.,2002,117, 131~141
[181] Iversen T. G., Skrettin G. G., Llorenre A., et al. Endosome to Golgi transport of ricin is independent of clathrin and of the Rab9 and Rab11 GTPase. Mol. Biol. Cell., 2001, 12: 2099~2107.
[182] Llorente A., Rapak A., Schmid S. L., et al. Expression of mutant dynamin inhibits toxicity and transport of endocytosed ricin to the Golgi apparatus. J. Cell. Biol., 1998a, 140: 1~11.
[183] Grimmer S, Iversen T. G , van Deurs B , et al. Endosome to Golgi transport of ricin is regulated by cholesterol. Mol. Biol. Cell., 2000, 11: 4205~4216.
[184] Birkeli K. A., Llorente A., Torgersen M. L, et al. Endosome-to-Golgi transport is regulated by protein kinase A type II alpha. J Biol Chem. 2003, 278: 1991~1997.
[185] Yoshida T, Chen C, Zhang M, et al. Disruption of the Golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin and Pseudomonas toxin. Exp Cell Res 1991; 192: 389~395.
[186] Prydz K, Hansen S H, Sandvig K, et al. Effects of brefeldin A on endocytosis, transcytosis and transport to the Golgi complex in polarized MDCK cells. J Cell Biol 1992; 119: 259~272.
[187] Okimoto T, Seguchi T, Ono M, et al. Brefeldin A protects ricin-induced cytotoxic ity in human cancer KB cell line, but not in its resistant counterpart with altered Golgi structures. Cell Struct Funct 1993; 18: 241~251.
[188] Boman A L, Kahn R A. Arf proteins: the membrane traffic police? Trends Biochem Sci 1995; 20: 147~150.
[189] Helms J B, Rothman J E. Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature 1992; 360: 352~354.
[190] Namibar MP, Wu HC. Ilimaquinone inhibits the cytotoxicities of ricin, diphtheria toxin, and other protein toxins in Vero cells. Exp Cell Res 1995; 219: 671~678.
[191] Simpson J C, Dascher C, Roberts L M, et al. Ricin cytotoxicity is sensitive to recycling between the endoplasmic reticulum and the Golgi complex. J Biol Chem 1995; 270: 20078~20083.
[192] Cosson P, Letourneur F. Coatomer interaction with di-lysine endoplasmic reticuthelum retention motifs. Science 1994; 263: 1629~1631.
[193] White J, Johannes L, Mallard F, et al. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J Cell Biol 1999; 147: 743~759.
[194] Jackson M E, Simpson J C, Girod A, et al. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J Cell Sci 1999; 112: 467~475.
[195] Chen A, Hu T, Mikoryak C, et al. Retrograde transport of protein toxins under conditions of COPI disfunction. Biochim Biophys Acta 2002; 1589: 124~139.
[196] Weche J., Rapak A., Olsnes S. Dependence of ricin toxicity on translocation of the toxin A chain from the endoplasmic reticulum to the cytosol. J. Biol. Chem., 1999, 274: 34443~34449.
[197] Michala K. M., Corbett E. F., Mesaelin, et al.Calreticulin: one protein, one gene, many functions. Biochem J., 1999, 344 (pt2) : 281~292.
[198] Day P. J., Owens S. R., Wesche J., et al. An interaction between ricin and calreticulin that may have implications for toxin trafficking. J. Biol. Chem. 2001, 276: 7202~7208.
[199] Roberts M. L., Smith C. D. Ricin: the endoplasmic reticulum connection. Toxicon, 2004, 44: 469~472.
[200] Girod A., Storrie B., Simpson J. C., et al. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol.,1999,1: 423~430.
[201] Spooner R. A., Watson P. D. Marsden C. J., et al. Protein disulphide- isomerase reduces ricin to it’s A and B chains in the endoplasmic reticulum. Biochem J., 2004,383: 285~293.
[202] Di Cola, A., Frigerio L., Lord J.M., et al. Ricin A chain without its partner B chain is degraded after retrotranslocation from the endoplasmic reticulum to the cytosol in plant cells. Proc. Natl Acad. Sci. USA, 2001, 98: 14726~14731.
[203] Mohanraj D., Ramakrishnan D.. Cytotoxic effects of ricin without an interchain disulfide bond: genetic modification and chemical crosslinking studies. Biochim Biophys Acta 1995, 1243: 399~406.
[204] Pelham H. R. B., Roberts L. M., Lord J. M. Toxin entry: how reversible is the secretory pathway? Trends Cell Biol 1992, 2: 183~185.
[205] Simpson J. C., Roberts L. M., Romisch K., et al. Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast. FEBS Letters, 1999, 459 (1) : 80~84.
[206] Day P. J., Pinheiro T. J., Roberts L. M., et al. Binding of ricin A- chain to negatively charged phospholipid vesicles leads to protein structural changes and destabilizes the lipid bilayer. Biochemistry, 2002, 41, 2836~2843.
[207] Slominska-Wojewodzka M, Gregers T. F., Walchli S, et al. EDEM Is Involved in Retrotranslocation of Ricin from the Endoplasmic Reticulum to the Cytosol. Mol Biol Cell., 2006, 17(4):1664~1675.
[208] Teter K., Holmes R.K. Inhibition of endoplasmic reticulumassociated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin. Infect. Immun. 2002,70: 6172~6179.
[209] Argent R. H., Parrott A. M., Day P. J., et al. Ribosome-mediated folding of partially unfolded ricin A chain. J Biol Chem. 2000, 275: 9263~9269.
[210] Jones N.L., Islur A., Haq R., et al. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J. Physiol Gastrointest Liver Physiol , 2000, 278: G811~G819.
[211] Suzuki A, Doi H, Matsuzawa F, et al.Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7. Genes Dev., 2000, 14: 1734~1740.
[212] Brodsky J L, McCracken A A. ER protein quality control and proteasome-mediated protein degradation. Semin Cell Dev Biol 1999; 10: 507~513.
[213] Pilon M, Shekman R, R¨omisch K, et al. Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J 1997; 16: 4540~4548.
[214] Plemper RK, B¨ohmler S, Bordallo J, et al. Mutant analysis links to the translocon and BiP to retrograde protein transport for ER degradation. Nature 1997; 388: 891~895.
[215] Vashist S, Kim W, Belden WJ, et al. Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J Cell Biol 2001; 155: 355~368.
[216] Caldwell SR, Hill KJ, Cooper AA. Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi. J Biol Chem 2001; 276: 23296~23303.
[217] Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature, 1999, 402: 715~720.
[218] Huang M, Jiang H, Qu X, Xu Z, Wang Y, Dong S. Small molecules as cross-linkers: fabrication of carbon nanotubesthionine self-assembled multilayers on amino functionalized surfaces Chem. ComMun. , 2005, 44: 5560~5562.
[219] Dey D, Bochkariov D E, Jokhadze G G, Traut R R. Cross-linking of Selected Residues in the N- and C-terminal Domains of Escherichia coli Protein L7/L12to Other Ribosomal Proteins and the Effect of Elongation Factor Tu J. B iol. Chem. , 1998, 273 (3) : 1670~1676.
[220] Huang M, Jiang H, Qu X, et al. Small molecules as cross-linkers: fabrication of carbon nanotubes/thionine self-assembled multilayers on amino functionalized surfaces Chem commun, 2005, 44:5560~5562.
[221] McMahoNS B, vaNBuskirk H A, DugaNK A, et al.Tumor Cell Intravasation A/u-cidated: The Chick Embryo Opens the Cofactor for the c-Myc and E-F On coproteins. Cell, 1998, 94 (3) : 363~374.
[222] Fitzgerald K. In vitro display technologies-new tools for drug discovery D rug D iscovery Today, 2000, 5 (6) : 253~258.
[223] Sui J, Li W, Murakami A, et al. A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Proc. Natl. Acad. Sci. USA, 2004, 101 (8) : 2536~2541.
[224] Kim J H, Hahm B, Kim Y K, et al. A. "Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm." J. Mol. B iol. , 2000, 298 (3) : 395~405.
[225] Kishimoto A, Ogura T, Esumi H. A pull-down assay for 5' AMP-activated protein kinase activity using. the GST-fused protein Mol Biotechnol. , 2006, 32 (1) : 17~21.
[226] Lu L, Tai G, Hong W. Arrays of Transfected Mammalian Cells for Pull-Down Experiments Methods Enzymol. , 2005, 404: 432~441.
[227] Gao Y K, Jiang M, Yang T, et al. Analysis of the Interaction between hPFTAIRE1 and PLZF in a Yeast Two-hybrid System Acta. Bioch. Bioph. S in. , 2006, 38 (3) : 164~170.
[228] Chairat T, Thawornchai L, Wiyada W, et al. Impaired interaction of α-haemoglobin- stabilising protein with α-globin termination mutant in a yeast two-hybrid system Brit. J. HaeMatol. , 2006, 132 (3) : 370~373
[229] 马慧莲, 刘含智, 王丽萍, 等. 量子点的荧光共振能量转移在生物分析中的应用分析化学, 2005, 33 (9) : 1335~1338.
[230] Biener E, Charlier M, Ramanuja N V K, et al. Quantitative FRET imaging ofleptin receptor oligomerization kinetics in single cells J. Biol. Cell, 2005, 97 (12) : 905~919.
[231] Yamamoto T, Lamoureux J , RyaNR O. Characterization of low density lipoprotein receptor ligand interactions by fluorescence resonance energy transfer J. Lipid Res. , 2006, 47 (5) : 1091~1096.
[232] Wang J J, Chen X C, Xing D. Prog Biochem Biophys, 2003, 30(6):980~983.
[233] Chairat T, Thawomchai L, Wiyada W, et al. Brit J Haenatol 2006,132(3): 370~373.
[234] YuaNC, Che N A, Kol B P, et al. Energy Landscape of Streptavidin-Biotin Complexes Measured by Atomic Force Microscopy BiocheMistry, 2000, 39 (33) : 10219~10223.
[235] Uetz P, Giot L, Cagney G, Mansfield T A, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae Nature, 2000, 403 (6770) : 623~627
[236] Ideker T, Thorsso N V, Ranish J A, et al. Glia-Synapse Interaction Through Ca2+-Permeable AMPA Receptors in Bergmann Glia Science, 2001, 292 (5518) : 929~934.
[237] GaviNA C, Bosche M, Krause R, et al. Functional organization of the yeast proteome by systematic analysis of protein complexes Nature, 2002, 415 (6868) : 141~147.
[238] Forler D, Kocher T, Rode M, et al. An efficient protein complex purification method for functional proteomics in higher eukaryotes Nat. Biotechnol. , 2003, 21 (1) : 89~92.
[239] Westwick J K, Michnick SW. Protein-Fragment Complementation Assays (PCA) in Small GTPase Research and Drug Discovery. Methods EnzyMol. , 2005, 407: 388~401.
[240]何为,许丹科, 刘志红. 蛋白质微阵列芯片技术及其在抗体筛选中的应用.分析化学, 2005, 33 (1) : 37~40.
[241] Jacobso N R H, Ladurner A G, King D S, et al. Structure and Function of a Human TAFII250 Double Bromodomain Module Science, 2000, 288 (5470) : 1422~1425.
[242] Thomas Proft, Norfolk, N J. Microbial Toxins: Molecular and Cellular Biology, ed .New York: Horizon Press, 2005. 473~496.
[243] Hosokawa N, Wada I, Hasegawa, K, et al. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep, 2001, 2: 415~422.
[244] Molinari M, Calanca V, Galli C, et al. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science, 2003, 299: 1397~1400.
[245] Oda Y, Hosokawa N, Wada I, et al. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science, 2003, 299: 1394~1397.
[246] Mast S W, Diekman K, Karaveg K, et al. Human EDEM2, A novel homolog of family 47 glycosidases, is involved in ER-associated degradation of glycoproteins. Glycobiology, 2004, 15: 421~436.
[247] Olivari S, Galli C, Alanen H, et al. A novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation. J Biol Chem, 2005, 280: 2424~2428.
[248] Sambrook J,Fritsch E F,Manitatis T.分子克隆实验(第二版).北京:科学出版社,1992
[249] Trefzer U, Weingart G, Chen Y, et al. Hybrid cell vaccination for cancer immune therapy: first clinical trial with matastatic melanoma. Int J Cancer, 2000, 85: 618~626。
[250] Simon S M, Blobel G.. A protein-conducting channel in the endoplasmic reticulum. Cell, 1991, 65: 371~380.。
[251] Lord M J, Jolliffe N A, Catherine J, et al. Ricin: Mechanisms of Cytotoxicity. Toxicol Rev, 2003, 22: 53~64。
[252] Pasqualato S, Renault L, Cherfils J. Arf, Arl, Arp and Sar proteins: a family of GTP-binding proteins with a structural device for “front-back” communication. Embo Reports, 2002, 3: 1035~1041.
[253] Lowe S L, Wong S H, Hong W. The mammalian ARF-like protein 1 (Arl1) is associated with the Golgi complex. Journal of Cell Science, 1996, 109: 209~220.
[254] Van Valkenburgh H, Shern J F, Sharer J D, et al. ADP-ribosylation factors (ARFs) and ARF-like 1 (ARL1) have both specific and shared effectors characterizingARL1-binding proteins. Journal of Biological Chemistry, 2001, 276: 22826~22837.
[255] Lu L, Horstmann H, Ng C, et al. Regulation of Golgi structure and function by ARF-like protein 1 (Arl1). Journal of Cell Science, 2001, 114: 4543~4555.
[256] Schurmann A, Massmann S, Joost H G. ARP is a plasma membrane-associated Ras-related GTPase with remote similarity to the family of ADP-ribosylation factors. Journal of Biological Chemistry, 1995, 270: 30657~30663.
[257] Shin H W, Kobayashi H, Masashi K, et al. Roles of ARFRP1 (ADP-ribosylation factor-related protein 1) in post-Golgi membrane trafficking. Journal of Cell Science, 2005, 118; 4039~4048。
[258] Liepinsh E. Baryshev A. Sharipo M. et al. Thioredoxin Fold as Homodimerization Module in the Putative Chaperone ERp29. NMR Structures of the Domains and Experimental Model of the 51 kDa Dimer, Structure . 2001, 9: 457~471.
[259] Hubbard M J, Mangum J E, McHugh N J. Purification and biochemical characterization of native ERp29 from rat liver, Biochem. J. 2004, 383: 589~597.
[260] Brian M, Emily K. R, Thomas B. ERp29 Triggers a Conformational Change in Polyomavirus to Stimulate Membrane Binding Mol Cell, 2005, 20, 289~300.
[261] Mikhail B, Ernest S, Souren M. ERp29 is an essential endoplasmic reticulum factor regulating secretion of thyroglobulin. Biochem Bio Res Com, 2006, 340: 617~624.
[2] Robert B, John F H, Mark A, et al. Ricin: mechanism of action, detection and intoxication. J Toxiol, 1995, 14: 483.
[3] Franz D R, Aaz N K. Medical aspects of chemical and biologicalwarfare, chapter 32, ricin toxin, fall church . VA: Office of the Surgeon General, 1997: 631
[4] Stillmark. Ueber Ricen. Arbeiten des Pharmacologischen Institutes zu Dorpat, iii, 1889. Cited in: Flexner. The histological changes produced by ricin and abrin intoxications. J Exp Med. 1897;2:197~216.
[5] Bernhijmer A W. Perspectives in toxinology, Abrin and Ricin: two toxic tectins inactivating eukaryotic ribosome. 1977, sju R. Olsnes(eds), Awiley Medical publication.
[6] Ehrlich P. Experimentelle Untersuchungen über Immunit?t, I: Euber Ricin. Deutsch Med Wochenschr. 1891;17:976~979
[7] Olsnes S, Pihl A. Abrin, ricin, and their associated agglutinins. In: Cuatrecasas P, ed. Receptors and Recognition: The Specificity and Action of Animal, Bacterial, and Plant Toxins. London, England: Chapman and Hall; 1976: 129~173.
[8] Olsnes S, Pihl A. Construction and properties of chimeric toxins target specific cytotoxic agents. In: Dorner F, Drews J, eds. Pharmacology of Bacterial Toxins. New York, NY: Pergamon Press; 1986: 709~739.
[9] Magerstadt M. Therapeutic aminoconjugates. In: Antibody Conjugates and Malignant Disease. Boca Raton, Fla: CRC Press; 1991: Chap 3.
[10] Ucken F, Frankel A. The current status of immunotoxins: An overview of experimental and clinical studies as presented at the 3rd International Symposium on Immunotoxins. Leukemia. 1993;7:341~348
[11] Vitetta E, Thorpe P, Uhr J. Immunotoxins: Magic bullets or misguided missiles? Trends Pharmacol Sci. 1993;14(5):148~154.
[12] Vitetta E, Krolick K, Muneo M, Cushley W, Uhr J. Immunotoxins: A new approach to cancer therapy. Science. 1983;219:644~649.
[13] Thorpe PE, Mason DW, Brown AN, et al. Selective killing of malignant cells in leukemic rat bone marrow using an antibody–ricin conjugate. Nature . 1982;297:594~596.
[14] Cookson J, Nottingham J. A Survey of Chemical and Biological Warfare. New York, NY: Monthly Review Press. 1969: 6.
[15] Ramesh Hegde. Studies of the variants of the protein toxins Ricin and Abrin. Eur. J.Biochem.1992, 204, 155~164.
[16] Cawley B D. Homogy between Ricin and Ricinus communis agglutinin: Amino terminal sequence analysis and protein synthesis inhibition studies. Archives of Biochemistry and Biophysics, 1978,190: 744~755.
[17] Lord J M, Roberts L M, Robertus J D, et al. Ricin: strcture, mode of actin and some current applications. FASEB J, 1994, 8: 201~204.
[18] Robertus J. Toxin structure. In: Frankel A, ed. Immunotoxins. Boston, Mass: Kluwer Academic Publishers; 1988: 11~24.
[19] Dietrich J B, Ribereau G G, Jung M L. Identity of the N-terminal sequences of the three A chains of mistletoe lectins: homology with ricin-like plant toxin and single-chain ribosome inhibiting proteins. Anticancer Drugs, 1992, 3: 507~511.
[20] Morris K N. Proc. Natl. Acad. Sci. USA, 1992,89:48~69.
[21] Katzin B J, Collins E J, Robertus J D. Structure of ricin A-chain at 2.5 A° . Proteins, 1991; 10: 251~259.
[22] Mlsna D, Monzingo A F, Katzin B J, et al. Structure of recombinant ricin A-chain at 2.3 A° resolution. Protein Sci 1993; 2: 429~435.
[23] Weston SA, Tucker AD, Thatcher DR, et al. X-ray structure of recombinant ricin A-chain at 1.8 A° resolution. J Mol Biol 1994; 244: 410~22.
[24] Burlet A, Chapleur C M, Haumont P B. Long-term reduction of vasopressin excretion induced by the central injection of an immunoconjugate. Neruoscience, 1992, 50: 965~973.
[25] Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain: mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 1987; 262: 8128~8130.
[26] Lewis M S, Youle R J. Ricin subunit association: thermodynamics and the role ofthe disulfide bond. J Biol Chem, 1986; 261: 11571~11577.
[27] Wright H T, Robertus J D. The intersubunit disulfide bridge of ricin is essential for cytotoxicity. Arch Biochem Biophys,1987; 256: 280~284.
[28] Endo Y, Tsurugi K. The RNA N-glycosidase activity of ricin A-chain. J Biol Chem 1988; 263: 8735~8739.
[29] Wool I G, Correll C C, Yuen-Ling C. Structure and function of the sarcin-ricin domain. In: Garrett J, Douthwaite L, Lilias P J, et al., editors. The ribosome structure, function, antibiotics and cellular interactions. Washington, DC: ASM Biochem, 1981; 119: 31~4 Press, 2000: 461~473.
[30] Ban N, Nissen P, Hansen J, et al. Placement of protein and RNA structures into a 5A° -resolution map of the 50S ribosomal subunit. Nature 1999; 400: 841~847.
[31] Sperti S, Montanaro L, Mattioli A, et al. Inhibition by ricin of protein synthesis in vitro: 60 S ribosomal subunit as the target of the toxin. Biochem J, 1973; 136: 813~815.
[32] Nilsson L, Nygard O. The mechanism of the protein synthesis elongation cycle in eukaryotes: effect of ricin on the ribosome interaction with elongation factors. Eur J Biochem, 1986; 161: 111~117.
[33] Hartley M R, Legname G, Osborn R, et al. Single-chain ribosome-inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett 1991; 290: 65~68.
[34] Cawley D B, Hedbolm M L, Hoffman E J, et al. Differential sensitivity of rat liver and wheat germ ribosomes to inhibition of polyuridylic acid translation by ricin A chain. Arch Biochem Biophys, 1977; 182: 690~695
[35] Monzingo A F, Robertus J D. X-ray analysis of substrate analogs in the ricin A- chain active site. J Mol Biol, 1992; 227: 1136~1145.
[36] Villafranca J E, Robertus J D. Ricin B chain is the product of gene duplication. J Biol Chem, 1981; 256: 554~556.
[37] Ramakrishnan S F, Mohavraj D. Cytotoxic conjugates containing translational inhibitory proteins, Ann Rev Pharmacol Toxicol, 1992, 32: 579.
[38] Magnusson S., Kjeken R., Berg T. Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells. Exp. Cell. Res., 1993, 205:118~125.
[39] Riccobono F., Fiani M. L. Mannose receptor dependent uptake of ricin A1 and A2 chains by macrophage. Carbohydr Res,1996, 282(2): 285~292.
[40] Fu T. ,Burbage C. and Tagge E. ,Double - lectin site ricin B chain mutants espressed in insect cells have residual galactose binding : evidence for more than two lectin site on the ricin toxin B chain.Bioconjug Chem, 1996 ;7 (6) :651~658.
[41] Barbieri L, Valbonesi P, Bonora E, et al. Polynucleotide: adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly A. Nucleic Acids Res, 1997; 25: 518~522.
[42] Brigotti M, Alfies R, Sestili P, et al. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J, 2002; 16: 365~372.
[43] Barbieri L, Valbonesi P, Righi F, et al. Polynucleotide: adenosine glycosidase is the sole activity of ribosome-inactivating proteins on DNA. J Biochem (Tokyo), 2000; 128: 883~889
[44] Day P J, Lord J M, Roberts L M. The deoxyribonuclease activity attributed to ribosome- inactivating proteins is due to contamination. Eur J Biochem, 1999; 258: 540~545.
[45] van Damme E, Hao Q, Chen Y, et al. Ribosome-inactivating proteins: a family of plant proteins that do more than inactivate ribosomes. Crit Rev Plant Sci, 2001; 20: 395~465
[46] Barbieri L, Valbonesi P, Bonora E. Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly A. Nucleic Acids Res, 1997; 25: 519~522
[47] Peumans W J, Hao Q, van Damme E J. Ribosome-inactivating proteins from plants: more that RNA N-glycosidases? FASEB J, 2001; 15: 1493~1506
[48] Balint G A. Ricin: The toxic protein of castor oil seeds. Toxicology, 1974;2(1): 77~102.
[49] Wannemaker R. Assistant Division Chief, Toxinology Division, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Md. Personal communication, September 1994.
[50] Lord J M, Roberts L M, Robertus J D. Ricin: structure, mode of action, and somecurrent applications. FASEB J 1994; 8: 201~208.
[51] Butterworth A G, Lord J M. Ricin and Ricinus communis agglutinin subunits are all derived from a single-size polypeptide precursor. Eur J Biochem 1983; 137: 56~62.
[52] Ferrini J B, Martin M, Taupiac M P, et al. Expression of functional ricin B chain using the baculovirus system. Eur J Biochem, 1995; 233: 772~777.
[53] Lamb F I, Roberts LM, Lord J M. Nucleotide sequence of cloned cDNA coding for preproricin. Eur J Biochem, 1985; 148: 265~270.
[54] Lord J M. Precursors of ricin and Ricinus communis agglutinin: glycosylation and processing during synthesis and intracellular transport. Eur J Biochem 1985; 146: 411~416.
[55] Roberts L M, Lord J M. The synthesis of Ricinus communis agglutinin. Eur J Biochem, 1981; 119: 31~34.
[56] Lord J M. Synthesis and intracellular transport of lectin and storage protein precur sors in endosperm from castor bean. Eur J Biochem 1985; 146: 403~409.
[57] Lord J M, Harley S M. Ricinus communis agglutinin B chain contains a fucosylated oligosaccharide side chain not present on ricin B chain. FEBS Lett, 1985: 189; 72~76
[58] Harley S M, Lord J M. In vitro endoproteolytic cleavage of castor bean lectin precursors. Plant Sci, 1985; 41: 111~116.
[59] Frigerio L, Vitale A, Lord J M, et al. Free ricin A chain, proricin and native toxin have different cellular fates when expressed in tobacco protoplasts. J Biol Chem, 1998; 273: 14194~14199.
[60] Frigerio L, Jolliffe N A, Di Cola A, et al. The internal propeptide of the ricin precursor carries a sequence-specific determinant for vacuolar sorting. Plant Physiol, 2001; 126: 167~175.
[61] Jolliffe N A, Ceriotti A, Frigerio L, et al. The position of the proricin vacuolar targeting signal is functionally important. Plant Mol Biol, 2003; 41: 825~835.
[62] Ramesh Hegde, et al. Studies of the variants of the protein toxins Ricin and Abrin. Eur. J.Biochem.1992, 204, 155~164.
[63] Sjur Olsnes, et al. Different biological properties of the two constituent peptidechains of ricin, a toxic protein inhibiting protein synthesis. Biochemistry, 1973,12: 3121~3126.
[64] Jon D, et al. Crystallization of Ricin A chain obtained from a cloned gene expressed in Escherichia coli. Biol Chem.,1987,262: 19~20.
[65] Hare O M, et al. Expression of Ricin A chain in Escherichia coli. FEBS Lett., 1987,216: 73~78.
[66] Hailling K, et al. Genomic cloning and characterization of a ricin gene from Ricinus communis Nucl.. Acids Res., 1985,13: 8019~8033.
[67] Tagge E P, et al. Preproricin expressed in Nicotiana tobacum cells in vitro is fully processed and biologically active. Protein Exprpurif, 1996,8: 109~118.
[68] Richardson P T, Westby M, Roberts L M, et al. Recombinant proricin binds galactose but does not depurinate 28S ribosomal RNA. FEBS Lett 1989; 255: 15~20.
[69] Lewis M S, Youle R J. Ricin subunit association: thermodynamics and the role of the disulfide bond. J Biol Chem, 1986; 261: 11571~11577.
[70] Wright H T, Robertus J D. The intersubunit disulfide bridge of ricin is essential for cytotoxicity. Arch Biochem Biophys, 1987; 256: 280~284.
[71] Harley S M, Beevers H. Ricin inhibition of in vivo protein synthesis by plant ribosomes. Proc Natl Acad Sci, 1982; 79: 5935~5938.
[72] Taylor S, Massiah A, Lomonossoff G, et al. Correlation between the activities of five ribosome-inactivating proteins in depurination of tobacco ribosomes and inhibition of tobacco mosaic virus infection. Plant J, 1994; 5: 827~835.
[73] Ghosh P, Wellner R, Cragoe E, Wu H. Enhacement of ricin cytotoxicity in Chinese hamster ovary cells by depletion of intracellular K+: Evidence for Na+/H+ exchange system in Chinese hamster ovary cells. J Cell Biol, 1985,101: 350~357.
[74] Moya M, Dautry-Varsat A, Goud B, Louvard D, Boquet P. Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diptheria toxin but not that of ricin toxin. J Cell Biol, 1985, 101(2): 548~559.
[75] Sandvig K, Olsnes S, Pihl A. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells. J Biol Chem, 1976, 251(13):3977~3984.
[76] Lord J M, Roberts L M, Robertus J D. Ricin: Structure, mode of action, and some current applications. FASEB J. 1994, 8:201~208.
[77] Hudson T, Neville D. Temporal separation of protein toxin translocation from processing events. J Biol Chem, 1987, 262:16484~16494.
[78] Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes: The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J Biol Chem. 1987;262(12):5908~5912.
[79] Olsnes S, Pihl A. Toxic lectins and related proteins. In: Cohen P, van Heyningen S, eds. Molecular Action of Toxins and Viruses. Amsterdam, Netherlands: Elsevier Biomedical Press; 1982: 51~105.
[80] Wilhelmsen C, Pitt L. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet Pathol, 1993, 30: 482
[81] Crompton R, Gall D. Georgi Markov: Death in a pellet. Med Leg J, 1980, 48: 51~62.
[82] Patocka J . Abrin and Ricin: two dangerous poisonous proteins. http://www.asabktr.cin/newsletter/01- 4/articles/Abrin &RicinRev.Pdf
[83] Kortepeter M, Christopher G, Cieslak J . et al . USAMR II D’ s Medical Management of Biological casualitites Handbook: Biological toixns. Fourth Edition. http://www.vnh.org/BIOCASU/toc.html
[84] Sjur O S, Refsnes K, Pihl A , et al. M echanism of action of the toxic lectins abrin and ricin. N ature, 1974, 249: 627~631.
[85] Olsnes S. Closing in on ricin action. Nature, 1987,328: 474~475.
[86] Fu T, Burbage C, Tagge E, et al. R icin toxin contains th ree lectin sites wh ich contribute to its in vivo toxicity. Int J Immunopharmaco l, 1996, 18: 685~692.
[87] Tracey K J , Beutler B, Lowry S F, et al. Shock and tissue injury induced by recombinant human cachetin. Science, 234: 470~474
[88] Licastro F, Morini M C, Bolognesi A , et al. Ricin induced the production of tumor necrosis facto ralpha and interleuk in 21 beta by human peripheral2blood mononuclear cells. Biochem J , 1993, 294: 517~520.
[89] Muldoon D F, Bagchi D, Hassoun E A , et al. Themodulating effects of tumo r necro sis factor alpha antibody on ricin-induced oxidative stress in mice. J Biochem Toxico, 1994, 9: 311~318.
[90] 董巨莹, 王剑波, 王文学. 蓖麻毒素诱导小鼠肝脏产生肿瘤坏死因子. 第四军医大学学报, 1997, 18: 78.
[91] Muldoon D F, Stohes S J. Ricin-induced oxidative stress in mice. Toxico logist, 1991, 11: 214.
[92] Muldoon D F, Hassoun E A , Stohs S J. Ricin-induced hepatic lipid peroxidation, glutathione depletion and DNA single-strand break s in mice. Toxicon, 1992, 30: 977~984.
[93] Corwin A H. Toxic constituents of the castor bean. J M ed Pharm Chem, 1961, 4: 483~496.
[94] Muldoon D F, Hassoun E A , Stohes S J. Ro le of iron in ricin-induced lipid peroxidation and superoxide production. Res Commun Mo Patho Pharmaco, 1996, 92: 107~118
[95] Leek M D, Griffiths G D, Green M A. Intestinal patho logy follow ing intramuscular ricin poisoning. J Patho l, 1989, 159: 329~334.
[96] Waring P. DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded raised ino sitotripho sphate levels. J Bio l Chem, 1990, 265: 14476~14480
[97] Khan T, Waring P. Macrophage adherence prevents apoptosis induced by ricin. Eur J Cell Bio l, 1993, 62: 406~414.
[98] 江渝. 程序型细胞死亡的生物化学基础. 国外医学临床生物化学与检验学分册, 1996, 17: 178~182.
[99] Benis J. Signal transduction via the MAP kinase: proceed at your own RSK. Proc Natl Acad Sci USA, 1993, 91: 5889~5992.
[100] Lin JY. A brin and ricin: New anti-tumour substances. Nature,1970;227(1):292.
[101] Sandra W Key, et al. Researchers know beans about cancer research. Cancer Weekly Plus, 1998,11: 20.
[102] Fred Wilson. Immunotoxin safely eliminates local inflammation in two days. Dermatology Times, 2000,21: 18~19.
[103] Weiner L M. Phase I evaluation of an antibreast carcinoma monoclonal antibody 260F9 ricin A chain. Cancer Res., 1989,49: 4062~4067.
[104] 董巨莹,等. 蓖麻毒素及其修饰物对 U937 细胞 IL21B 和 TNF2A 的诱导作用. 细胞与分子免疫学杂志, 1999,15:123~125.
[105] 张会. 包有蓖麻毒素脂质体的制备、性质及毒性研究. 生物化学与生物物理学报, 1999,31: 472~474.
[106] Chignola R. Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with vira l structures. J Bio Chem, 1995,207: 23345~23351.
[107] Lord J. Ricin: structure, mode of action, and some current applications. FASEB J., 1994,8: 201~208.
[108] Lambert J M. , Goldmacher V S. ,and Collinson A R. ,et al. An Immuntoxin prepared with blocked ricin :a natural plant toxin adaped for therapeutic use. Cancer Res. 1991 ;51 (23) :6236~6242
[109] Lambert J M. , Goldmacher V S. ,and Collinson A R. ,et al. An Immuntoxin prepared with blocked ricin :a natural plant toxin adaped for therapeutic use. Cancer Res. 1991 ;51 (23) :6236~6242
[110] 沈演初. 生物农药. 北京: 化学工业出版社, 2000. 72~98.
[111] 赵善欢. 植物化学保护. 北京: 中国农业出版社, 2002. 301~303.
[112] 杜小凤. 植物源农药研究进展. 农药, 2000, 11: 8~10
[113] 蔡东宏. 用淘米水和蓖麻籽的熬出物防治椰子害虫. 世界农业信息, 1995. 9, 69.
[114] 赵建兴. 蓖麻毒素粗提物杀虫作用的研究. 内蒙古农业大学学报, 2001,12: 78~80.
[115] Maruniak J E. Susceptibility of insect cells and ribosomes to ricin. Comparative Biochemistry and Physiology, 1990,96: 543~548.
[116] Frigerio L. The enemy within: Ricin and plant cells. J Exp Botany, 1998,326: 1473~1480.
[117] 吴文君, 胡兆农. 我国植物源害虫控制剂的研究与开发. 农药, 1999, 34(2) : 628.
[118] Sandvig, K. and van Deurs, B. Physiol. Rev, 1996, 76, 949~966.
[119] Llorente, A., Rapak, A., Schmid, S.L., et al. J. Cell Biol, 1998, 140, 1~11.
[120] Rodal, S.K., Skretting, G., Garred, ò., et al. Mol. Biol. Cell , 1999, 9, 472~474.
[121] Sandvig K, van Deurs B. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J, 2000, 19(22): 5943~5950.
[122] Sandvig K, Olsnes S, Pihl A. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells. J Biol Chem, 1976, 251: 3977~3984.
[123] Riccobono F., Fiani M. L. Mannose receptor dependent uptake of ricin A1 and A2 chains by macrophage Carbohydr Res,1996, 282(2): 285~292.
[124] Sandvig, K., Olsnes, S., Petersen, O.W. et al. J. Cell Biol,1987, 105, 679~689.
[125] Sandvig, K. van Deurs, B. Physiol. Rev. 1996, 76, 949~966.
[126] Larkin, J.M., Brown, M.S., Goldstein, J.L. et al. Cell, 1983,33, 273~285.
[127] Moya, M., Datry-Varsat, A., Goud, B., et al. J. Cell Biol, 1985,101, 548~559.
[128] Llorente, A., Rapak, A., Schmid, S.L., et al. J. Cell Biol, 1998, 140, 1~11.
[129] Damke, H., Baba, T., Warnock, D.E. et al. J. Cell Biol, 1994, 127, 915~934.
[130] Liu, S.H., Marks, M.S. Brodsky, F.M. J. Cell Biol, 1998, 140, 1023~1037.
[131] Parton, R.G., Joggerst, B. Simons, K. J. Cell Biol,1994, 127, 1199~1215.
[132] Oh, P., McIntosh, D.P. Schnitzer, J.E. J. Cell Biol, 1998, 141, 101~104.
[133] Henley, J.R., Krueger, E.W.A., Oswald, B.J. et al. J. Cell Biol, 1998, 141, 85~99.
[134] Stang, E., Kartenbeck, J. Parton, R.G. Mol. Biol. Cell,1997, 8, 47~57.
[135] Anderson, H.A., Chen, Y. Norkin, L.C. J. Gen. Virol, 1998, 79, 1469~1477.
[136] Subtil, A., He¨mar, A. Dautry-Varsat, A. J. Cell Sci, 1994, 107, 3461~3468.
[137] Fra A M., Williamson E., Simons K, et al. J. Biol. Chem, 1994, 269, 30745~30748.
[138] Eker P., Holm P K., van Deurs, B, et al. J. Biol. Chem, 1994,269, 18607~18615.
[139] Holm P K, Eker P, Sandvig K et al. Exp.Cell Res, 1995,217, 157~168.
[140] Llorente A., Garred ò., Holm P K., et al. Exp. Cell Res, 1996, 227, 298~308.
[141] Vogel U, Sandvig K, van Deurs B. J. Cell Sci, 1998,111: 825~832.
[142] Scheiele P, Verkade P, Fra A.M et al. J. Cell Biol, 1998, 140: 795~806.
[143] Rothberg K G, Ying Y S, Kamen B A et al. J. Cell Biol, 1990, 111: 2931~2938.
[144] Schnitzer J E. Oh P, Pinney E, et al. J. Cell Biol, 1994,127: 1217~1232.
[145] Pitha J, Irie T, Sklar P B et al. Life Sci, 1988, 43: 493~502.
[146] Hailstones D, Sleer L S, Parton R G et al. J. Lipid Res, 1998,39: 369~379.
[147] Araki N, Johnson M T, Swanson J A. J. Cell Biol, 1996, 135: 1249~1260.
[148] Artalejo C R, Henley J.R, McNiven M A, et al. Proc. Natl Acad Sci, 1995, 92: 8328~8332.
[149] Garred ?., Rodal S. K., van Deurs B., et al. Reconstitution of clathrin- indepe- ndent endocytosis at the apical domain of permeabilized MDCK Ⅱ cells: requirement for a Rho-family GTPase. Traffic 2001, 2: 26~36.
[150] van der Bliek A M, Redelmeier T E, Damke H, et al. J. Cell Biol, 1993, 122: 553~565.
[151] Kirchhausen T. Curr Opin Struct Biol, 1993, 3: 182~188.
[152] Zhang J, Ferguson S S G, Barak L S, et al. J. Biol. Chem, 1996,271: 18302~18305.
[153] Pals-Rylaarsdam R, Gurevich V V, Lee K B, et al. J. Biol. Chem,1997, 272: 23682~23689.
[154] Vickery R G, Zastrow M. J. Cell Biol, 1999, 144: 31~43.
[155] Cao T T, Mays R W, von Zastrov M. J. Biol Chem, 1998, 273: 24592~24602.
[156] Mihail M, Alex T, Natalia M, et al. Endosomal ricin transport:involvement of Rab4- and Rab5-positive compartments. Histochem Cell Biol, 2004, 121: 429~439.
[157] Rodal S.K., Skretting G., Garred, ?., et al. Extraction of cholesterol with methyl-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell, 1999, 10: 961~974.
[158] Rothberg K. G., Ying Y. S., Kamen B. A., et al. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5- methyltetrahydrofolate. J Cell Biol. 1990, 111: 2931~2938.
[159] Lamaze C., Dujeancourt A., Baba T., et al. Interleukin receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell., 2001, 7: 661~671.
[160] Anderson H A, Chen Y, Norkin L C: Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 1996, 7(11):1825~1834.
[161] Pelkmans L, Puntener D, Helenius A: Local actin polymerization and dynaminrecruitment in SV40-induced internalization of caveolae. Science 2002, 296(5567):535~539.
[162] Gilbert J M,artenbeck J, Parton R G: Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 1997, 8(1):47~57.
[163] Gilbert J M, Goldberg I G, Benjamin T L: Cell penetration and trafficking of polyomavirus. J Virol 2003, 77(4):2615~2622.
[164] Gilbert J M, Benjamin T L: Early steps of polyomavirus entry into cells. J Virol 2000, 74(18):8582~8588.
[165] Richterova Z, Liebl D, Horak M,et al: Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol 2001, 75(22):10880~10891.
[166] Damm E M, Pelkmans L, Kartenbeck J,et al: Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol, 2005, 168(3):477~488.
[167] van Deurs B, Tonnessen T. I., Petersen O.W., et al. Routing of internalized ricin and ricin conjugates to the Golgi complex. J Cell Biol., 1986,102: 37~47.
[168] J ? rgen Wesche. Retrograde transport of ricin. IJMM, 2002,291: 517~521.
[169] Ghosh R. An endocytosed TGN38 chimeric protein is delivered to the TGN after trafficking through the endocytic recycling compartment in CHO cells. J Cell Biol 1998, 142:923~936.
[170] Mallard F, Antony C, Tenza D, et al: Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol 1998, 143(4):973~990.
[171] Mallard F, Tang BL, Galli T, et al: Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J Cell Biol 2002, 156(4):653~664.
[172] Mallet W G, Maxfield F R: Chimeric forms of furin and TGN38 are transported with the plasma membrane in the trans-Golgi network via distinct endosomal pathways. J Cell Biol 1999, 146:345~359.
[173] Lombardi D, Soldati T, Riederer M A, et al: Rab9 functions in transport between late endosomes and the trans Golgi network. Embo J 1993, 12(2):677~682.
[174] Sandvig K, Grimmer S, Lauvrak S U, et al: Pathways followed by ricin and Shiga toxin into cells. Histochem Cell Biol, 2002, 117(2):131~141.
[175] Sandvig K, Deurs B. van. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev.,1996, 76: 949~966.
[176] Clague M. J, Urbe S., Aniento F., et al. Vacuolar ATPase activity required for endosomal carrier vesicle formation. J. Biol. Chem.,1994,269:21~24.
[177] Holm P. K, Eker P., Sandvig K., et al. Phorbol myristate acetate selectively stimulates apical endocytosis via protein kinase C in polarized MDCK cells. Exp. Cell Res. 1995., 217: 157~168.
[178] Smith D. C., Gallimore A., Jones E., et al. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processingindependent MHC class I-restricted presentation. J. Immunol., 2002,169, 99~107.
[179] Sandvig K. Bo van Deurs. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS, 2002(529): 49~53.
[180] Sandvig, K., Grimmer, S., Lauvrak, S. U., et al. Pathways followed by ricin and Shiga toxin into cells. Histochem. Cell. Biol.,2002,117, 131~141
[181] Iversen T. G., Skrettin G. G., Llorenre A., et al. Endosome to Golgi transport of ricin is independent of clathrin and of the Rab9 and Rab11 GTPase. Mol. Biol. Cell., 2001, 12: 2099~2107.
[182] Llorente A., Rapak A., Schmid S. L., et al. Expression of mutant dynamin inhibits toxicity and transport of endocytosed ricin to the Golgi apparatus. J. Cell. Biol., 1998a, 140: 1~11.
[183] Grimmer S, Iversen T. G , van Deurs B , et al. Endosome to Golgi transport of ricin is regulated by cholesterol. Mol. Biol. Cell., 2000, 11: 4205~4216.
[184] Birkeli K. A., Llorente A., Torgersen M. L, et al. Endosome-to-Golgi transport is regulated by protein kinase A type II alpha. J Biol Chem. 2003, 278: 1991~1997.
[185] Yoshida T, Chen C, Zhang M, et al. Disruption of the Golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin and Pseudomonas toxin. Exp Cell Res 1991; 192: 389~395.
[186] Prydz K, Hansen S H, Sandvig K, et al. Effects of brefeldin A on endocytosis, transcytosis and transport to the Golgi complex in polarized MDCK cells. J Cell Biol 1992; 119: 259~272.
[187] Okimoto T, Seguchi T, Ono M, et al. Brefeldin A protects ricin-induced cytotoxic ity in human cancer KB cell line, but not in its resistant counterpart with altered Golgi structures. Cell Struct Funct 1993; 18: 241~251.
[188] Boman A L, Kahn R A. Arf proteins: the membrane traffic police? Trends Biochem Sci 1995; 20: 147~150.
[189] Helms J B, Rothman J E. Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature 1992; 360: 352~354.
[190] Namibar MP, Wu HC. Ilimaquinone inhibits the cytotoxicities of ricin, diphtheria toxin, and other protein toxins in Vero cells. Exp Cell Res 1995; 219: 671~678.
[191] Simpson J C, Dascher C, Roberts L M, et al. Ricin cytotoxicity is sensitive to recycling between the endoplasmic reticulum and the Golgi complex. J Biol Chem 1995; 270: 20078~20083.
[192] Cosson P, Letourneur F. Coatomer interaction with di-lysine endoplasmic reticuthelum retention motifs. Science 1994; 263: 1629~1631.
[193] White J, Johannes L, Mallard F, et al. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J Cell Biol 1999; 147: 743~759.
[194] Jackson M E, Simpson J C, Girod A, et al. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J Cell Sci 1999; 112: 467~475.
[195] Chen A, Hu T, Mikoryak C, et al. Retrograde transport of protein toxins under conditions of COPI disfunction. Biochim Biophys Acta 2002; 1589: 124~139.
[196] Weche J., Rapak A., Olsnes S. Dependence of ricin toxicity on translocation of the toxin A chain from the endoplasmic reticulum to the cytosol. J. Biol. Chem., 1999, 274: 34443~34449.
[197] Michala K. M., Corbett E. F., Mesaelin, et al.Calreticulin: one protein, one gene, many functions. Biochem J., 1999, 344 (pt2) : 281~292.
[198] Day P. J., Owens S. R., Wesche J., et al. An interaction between ricin and calreticulin that may have implications for toxin trafficking. J. Biol. Chem. 2001, 276: 7202~7208.
[199] Roberts M. L., Smith C. D. Ricin: the endoplasmic reticulum connection. Toxicon, 2004, 44: 469~472.
[200] Girod A., Storrie B., Simpson J. C., et al. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol.,1999,1: 423~430.
[201] Spooner R. A., Watson P. D. Marsden C. J., et al. Protein disulphide- isomerase reduces ricin to it’s A and B chains in the endoplasmic reticulum. Biochem J., 2004,383: 285~293.
[202] Di Cola, A., Frigerio L., Lord J.M., et al. Ricin A chain without its partner B chain is degraded after retrotranslocation from the endoplasmic reticulum to the cytosol in plant cells. Proc. Natl Acad. Sci. USA, 2001, 98: 14726~14731.
[203] Mohanraj D., Ramakrishnan D.. Cytotoxic effects of ricin without an interchain disulfide bond: genetic modification and chemical crosslinking studies. Biochim Biophys Acta 1995, 1243: 399~406.
[204] Pelham H. R. B., Roberts L. M., Lord J. M. Toxin entry: how reversible is the secretory pathway? Trends Cell Biol 1992, 2: 183~185.
[205] Simpson J. C., Roberts L. M., Romisch K., et al. Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast. FEBS Letters, 1999, 459 (1) : 80~84.
[206] Day P. J., Pinheiro T. J., Roberts L. M., et al. Binding of ricin A- chain to negatively charged phospholipid vesicles leads to protein structural changes and destabilizes the lipid bilayer. Biochemistry, 2002, 41, 2836~2843.
[207] Slominska-Wojewodzka M, Gregers T. F., Walchli S, et al. EDEM Is Involved in Retrotranslocation of Ricin from the Endoplasmic Reticulum to the Cytosol. Mol Biol Cell., 2006, 17(4):1664~1675.
[208] Teter K., Holmes R.K. Inhibition of endoplasmic reticulumassociated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin. Infect. Immun. 2002,70: 6172~6179.
[209] Argent R. H., Parrott A. M., Day P. J., et al. Ribosome-mediated folding of partially unfolded ricin A chain. J Biol Chem. 2000, 275: 9263~9269.
[210] Jones N.L., Islur A., Haq R., et al. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J. Physiol Gastrointest Liver Physiol , 2000, 278: G811~G819.
[211] Suzuki A, Doi H, Matsuzawa F, et al.Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7. Genes Dev., 2000, 14: 1734~1740.
[212] Brodsky J L, McCracken A A. ER protein quality control and proteasome-mediated protein degradation. Semin Cell Dev Biol 1999; 10: 507~513.
[213] Pilon M, Shekman R, R¨omisch K, et al. Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J 1997; 16: 4540~4548.
[214] Plemper RK, B¨ohmler S, Bordallo J, et al. Mutant analysis links to the translocon and BiP to retrograde protein transport for ER degradation. Nature 1997; 388: 891~895.
[215] Vashist S, Kim W, Belden WJ, et al. Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J Cell Biol 2001; 155: 355~368.
[216] Caldwell SR, Hill KJ, Cooper AA. Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi. J Biol Chem 2001; 276: 23296~23303.
[217] Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature, 1999, 402: 715~720.
[218] Huang M, Jiang H, Qu X, Xu Z, Wang Y, Dong S. Small molecules as cross-linkers: fabrication of carbon nanotubesthionine self-assembled multilayers on amino functionalized surfaces Chem. ComMun. , 2005, 44: 5560~5562.
[219] Dey D, Bochkariov D E, Jokhadze G G, Traut R R. Cross-linking of Selected Residues in the N- and C-terminal Domains of Escherichia coli Protein L7/L12to Other Ribosomal Proteins and the Effect of Elongation Factor Tu J. B iol. Chem. , 1998, 273 (3) : 1670~1676.
[220] Huang M, Jiang H, Qu X, et al. Small molecules as cross-linkers: fabrication of carbon nanotubes/thionine self-assembled multilayers on amino functionalized surfaces Chem commun, 2005, 44:5560~5562.
[221] McMahoNS B, vaNBuskirk H A, DugaNK A, et al.Tumor Cell Intravasation A/u-cidated: The Chick Embryo Opens the Cofactor for the c-Myc and E-F On coproteins. Cell, 1998, 94 (3) : 363~374.
[222] Fitzgerald K. In vitro display technologies-new tools for drug discovery D rug D iscovery Today, 2000, 5 (6) : 253~258.
[223] Sui J, Li W, Murakami A, et al. A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Proc. Natl. Acad. Sci. USA, 2004, 101 (8) : 2536~2541.
[224] Kim J H, Hahm B, Kim Y K, et al. A. "Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm." J. Mol. B iol. , 2000, 298 (3) : 395~405.
[225] Kishimoto A, Ogura T, Esumi H. A pull-down assay for 5' AMP-activated protein kinase activity using. the GST-fused protein Mol Biotechnol. , 2006, 32 (1) : 17~21.
[226] Lu L, Tai G, Hong W. Arrays of Transfected Mammalian Cells for Pull-Down Experiments Methods Enzymol. , 2005, 404: 432~441.
[227] Gao Y K, Jiang M, Yang T, et al. Analysis of the Interaction between hPFTAIRE1 and PLZF in a Yeast Two-hybrid System Acta. Bioch. Bioph. S in. , 2006, 38 (3) : 164~170.
[228] Chairat T, Thawornchai L, Wiyada W, et al. Impaired interaction of α-haemoglobin- stabilising protein with α-globin termination mutant in a yeast two-hybrid system Brit. J. HaeMatol. , 2006, 132 (3) : 370~373
[229] 马慧莲, 刘含智, 王丽萍, 等. 量子点的荧光共振能量转移在生物分析中的应用分析化学, 2005, 33 (9) : 1335~1338.
[230] Biener E, Charlier M, Ramanuja N V K, et al. Quantitative FRET imaging ofleptin receptor oligomerization kinetics in single cells J. Biol. Cell, 2005, 97 (12) : 905~919.
[231] Yamamoto T, Lamoureux J , RyaNR O. Characterization of low density lipoprotein receptor ligand interactions by fluorescence resonance energy transfer J. Lipid Res. , 2006, 47 (5) : 1091~1096.
[232] Wang J J, Chen X C, Xing D. Prog Biochem Biophys, 2003, 30(6):980~983.
[233] Chairat T, Thawomchai L, Wiyada W, et al. Brit J Haenatol 2006,132(3): 370~373.
[234] YuaNC, Che N A, Kol B P, et al. Energy Landscape of Streptavidin-Biotin Complexes Measured by Atomic Force Microscopy BiocheMistry, 2000, 39 (33) : 10219~10223.
[235] Uetz P, Giot L, Cagney G, Mansfield T A, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae Nature, 2000, 403 (6770) : 623~627
[236] Ideker T, Thorsso N V, Ranish J A, et al. Glia-Synapse Interaction Through Ca2+-Permeable AMPA Receptors in Bergmann Glia Science, 2001, 292 (5518) : 929~934.
[237] GaviNA C, Bosche M, Krause R, et al. Functional organization of the yeast proteome by systematic analysis of protein complexes Nature, 2002, 415 (6868) : 141~147.
[238] Forler D, Kocher T, Rode M, et al. An efficient protein complex purification method for functional proteomics in higher eukaryotes Nat. Biotechnol. , 2003, 21 (1) : 89~92.
[239] Westwick J K, Michnick SW. Protein-Fragment Complementation Assays (PCA) in Small GTPase Research and Drug Discovery. Methods EnzyMol. , 2005, 407: 388~401.
[240]何为,许丹科, 刘志红. 蛋白质微阵列芯片技术及其在抗体筛选中的应用.分析化学, 2005, 33 (1) : 37~40.
[241] Jacobso N R H, Ladurner A G, King D S, et al. Structure and Function of a Human TAFII250 Double Bromodomain Module Science, 2000, 288 (5470) : 1422~1425.
[242] Thomas Proft, Norfolk, N J. Microbial Toxins: Molecular and Cellular Biology, ed .New York: Horizon Press, 2005. 473~496.
[243] Hosokawa N, Wada I, Hasegawa, K, et al. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep, 2001, 2: 415~422.
[244] Molinari M, Calanca V, Galli C, et al. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science, 2003, 299: 1397~1400.
[245] Oda Y, Hosokawa N, Wada I, et al. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science, 2003, 299: 1394~1397.
[246] Mast S W, Diekman K, Karaveg K, et al. Human EDEM2, A novel homolog of family 47 glycosidases, is involved in ER-associated degradation of glycoproteins. Glycobiology, 2004, 15: 421~436.
[247] Olivari S, Galli C, Alanen H, et al. A novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation. J Biol Chem, 2005, 280: 2424~2428.
[248] Sambrook J,Fritsch E F,Manitatis T.分子克隆实验(第二版).北京:科学出版社,1992
[249] Trefzer U, Weingart G, Chen Y, et al. Hybrid cell vaccination for cancer immune therapy: first clinical trial with matastatic melanoma. Int J Cancer, 2000, 85: 618~626。
[250] Simon S M, Blobel G.. A protein-conducting channel in the endoplasmic reticulum. Cell, 1991, 65: 371~380.。
[251] Lord M J, Jolliffe N A, Catherine J, et al. Ricin: Mechanisms of Cytotoxicity. Toxicol Rev, 2003, 22: 53~64。
[252] Pasqualato S, Renault L, Cherfils J. Arf, Arl, Arp and Sar proteins: a family of GTP-binding proteins with a structural device for “front-back” communication. Embo Reports, 2002, 3: 1035~1041.
[253] Lowe S L, Wong S H, Hong W. The mammalian ARF-like protein 1 (Arl1) is associated with the Golgi complex. Journal of Cell Science, 1996, 109: 209~220.
[254] Van Valkenburgh H, Shern J F, Sharer J D, et al. ADP-ribosylation factors (ARFs) and ARF-like 1 (ARL1) have both specific and shared effectors characterizingARL1-binding proteins. Journal of Biological Chemistry, 2001, 276: 22826~22837.
[255] Lu L, Horstmann H, Ng C, et al. Regulation of Golgi structure and function by ARF-like protein 1 (Arl1). Journal of Cell Science, 2001, 114: 4543~4555.
[256] Schurmann A, Massmann S, Joost H G. ARP is a plasma membrane-associated Ras-related GTPase with remote similarity to the family of ADP-ribosylation factors. Journal of Biological Chemistry, 1995, 270: 30657~30663.
[257] Shin H W, Kobayashi H, Masashi K, et al. Roles of ARFRP1 (ADP-ribosylation factor-related protein 1) in post-Golgi membrane trafficking. Journal of Cell Science, 2005, 118; 4039~4048。
[258] Liepinsh E. Baryshev A. Sharipo M. et al. Thioredoxin Fold as Homodimerization Module in the Putative Chaperone ERp29. NMR Structures of the Domains and Experimental Model of the 51 kDa Dimer, Structure . 2001, 9: 457~471.
[259] Hubbard M J, Mangum J E, McHugh N J. Purification and biochemical characterization of native ERp29 from rat liver, Biochem. J. 2004, 383: 589~597.
[260] Brian M, Emily K. R, Thomas B. ERp29 Triggers a Conformational Change in Polyomavirus to Stimulate Membrane Binding Mol Cell, 2005, 20, 289~300.
[261] Mikhail B, Ernest S, Souren M. ERp29 is an essential endoplasmic reticulum factor regulating secretion of thyroglobulin. Biochem Bio Res Com, 2006, 340: 617~624.